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Mycotoxins pose a serious threat to global food security due to their ubiquitous presence in food and feed 
crops. Mycotoxins became the subject of intense research when aflatoxin was implicated in “turkey X 
disease”, and subsequently many other mycotoxins have been deemed hazardous. Mycotoxins are of 
particular concern in Africa where environmental factors contribute to accelerated fungal growth and 
production of toxins; this coupled with poor understanding of the population on mycotoxin contamination 
and lack of regulatory measures highlight the need for active rather than reactive research into the 
molecular mechanisms of toxicity. 
Fusarium spp, are common contaminants of maize and produce a plethora of mycotoxins, including the 
neglected fusariotoxin fusaric acid (FA). Fusaric acid is described as a putative mitochondrial toxin and 
the canonical mechanism of FA toxicity is associated with the induction of oxidative stress; however its 
molecular mechanisms of toxicity are not fully elucidated. This study aimed to investigate the molecular 
mechanisms underlying FA-induced mitochondrial dysfunction and its effects on inflammation, cell stress 
responses and cellular metabolic processes in human hepatocellular carcinoma (HepG2) cells. 
It is well-established that mitochondria are the major sources of reactive oxygen species (ROS) and 
damage associated molecular patterns (DAMPs) that activate inflammatory responses via nucleotide-
binding domain (NOD)-like receptor protein 3 (NLRP3). Chronic inflammation or aberrantly regulated 
activation will result in pathological outcomes. However, the selective elimination of dysfunctional 
mitochondria via autophagy can maintain mitochondrial homeostasis and protect against the 
hyperinflammation induced by ROS and DAMPs. The effects of FA (25, 50, 104 and 150 μg/mL, 24 
hours) on interleukin-1β (IL-1β) processing, NLRP3 inflammasome priming and activation along with the 
potential of FA to initiate anti-inflammatory and cytoprotective responses through mitophagy were 
investigated. Fusaric acid disrupted synthesis and maturation of IL-1β by inhibiting NRLP3 priming and 
activation. Activation of NF-κB, a master regulator of inflammatory responses, was inhibited by FA 
through downregulation of upstream activator regulators - IKKβ, TRAF6, IRAK1 and IRAK4. Further 
experimentation revealed an up-regulation of NRF2 with concomitant elevation in the antioxidant enzyme 
SOD2 and autophagy/mitophagy markers suggesting that FA induces NRF2 cytoprotective programs and 
removal of damaged mitochondria in these cells. These results provide insight into a novel mechanism of 
immune dysregulation by FA. 
 xx 
 
Metabolic flexibility defines the capacity of cells to respond to changes in nutrient status. Mitochondria 
are important mediators of metabolic flexibility and dysfunction is associated with metabolic inflexibility 
and pathology. Foodborne toxins are often overlooked as potential factors contributing to metabolic 
toxicity. Thus, the effects of FA on energy homeostasis in cultured human liver (HepG2) cells were 
evaluated. HepG2 cells poised to undergo oxidative and glycolytic metabolism were exposed to a range of 
FA concentrations (4, 63 and 250 μg/mL) for 6 hours. The data connects a constitutive expression of HIF-
1α in response to FA to the inhibition of pyruvate decarboxylation through up-regulation of PDK-1 and 
phosphorylation of pyruvate dehydrogenase E1α subunit. There was a loss of ATP and metabolite shunt 
to lactate production in oxidatively poised HepG2 cells. This was confirmed by elevated expression of 
PKM2 and LDHa Moreover, the potential of FA to induce a glucose “addiction” and phenotype 
reminiscent of the Warburg effect is highlighted. The findings provide novel insights into the impact of 
this neglected foodborne mycotoxin in the dysregulation of energy metabolism. 
Fusaric acid is a niacin related compound and established chelator of divalent cations. This mycotoxin is a 
putative mitochondrial toxin and inducer of oxidative stress. Mitochondrial sirtuins are NAD dependent 
deacetylases that play a critical role in cytoprotection against oxidative and mitochondrial stressors as 
well as maintaining metabolic flexibility. The role of FA in the dysregulation of the mitochondrial SIRTs 
(3and 5) was examined in this study. Molecular docking revealed strong ligand affinity of FA to all 
mitochondrial SIRTs, with SIRT3 showing the highest binding affinity. The results indicate that FA binds 
to the active site of SIRT3 preventing binding of NAD (co-factor). All SIRTs were down regulated at the 
protein level but showed elevated mRNA expression. The expression profile of the common transcription 
factor, PGC-1α showed strong induction at the protein level suggesting that FA affects SIRT translational 
processes. The phosphorylation status of eif2α (an indicator of translational inhibition) was elevated. 
Furthermore, the expression profile of miRNA 30c, which suppresses SIRT translation was significantly 
elevated. The study suggests that FA inhibits SIRT activity; moreover this mycotoxin hinders SIRT 
expression through interference with translational and transcriptional processes as well as removal of zinc 
ions needed for SIRT stability. 
In conclusion, FA mediated mitochondrial stress induced cytoprotective mechanisms that perturb cellular 
homeostasis leading to aberrant inflammatory processes and energy metabolism. Foodborne toxins 
contribute to mitochondrial toxicity and may have implications in disease conditions such as cancer and 





INKULUMO YOPHANDO EFINGQIWE 
Ama-Mycotoxins atshengisa ubungozi obusiriyasi ekudleni emhlabeni jikelele ngenxa yokuba a-
ubiquitous ngobukhona bawo ekudleni nase makhobeni okudliwa yimfuyo. Ama- Mycotoxins aba 
undabuzekwayo kuphando ngenkathi u-aflatoxin wayesoleka kwi “turkey X disease”, kuphinde nje 
emvakwalokho asemaningi amanye ama-mycotoxins esevezwe njenganobungozi. Ama-mycotoxins 
ayinkinga kakhulu e-Africa lapho isimo sendawo sinomuthelela ekukhuleni ngokushesha kwe-fungal 
nokukhiqizeka kwama-toxins; lokhu kuhambisana nokungabi nolwazi oluphusile emuphakathini 
mayelana nezinhlobo zama- mycotoxin contamination kanti nokuxega kwemigomo nemibandela kuveza 
isidingo sokwenza umunyakazo ngophando lwe-molecular mechanisms ye-toxicity. 
I-Fusarium spp, abangcolisi abadumile bombila phinde nje bakhiqize inqwaba yama- mycotoxins, Kanye 
Kanye nalena enganakiwe i-fusariotoxin fusaric acid (FA). I-Fusaric acid ichazwe njenge mbangela ye-
mitochondrial toxin kuphinde nje i-mechanism evamile ye-FA toxicity ibandakanyeka nokukhiqizeka 
kwe-oxidative stress; kodwa ke ama-molecular mechanisms ayo ukuze ibe i-toxicity ebengakaze avezwe 
kahle ngokuphelele. Ucwaningo lolu luhlose ukuphanda kabanzi ama-molecular mechanisms 
ayimbangela ye-FA-induced mitochondrial dysfunction Kanye negalelo kwi-inflammation, ukuzivikela 
kweseli ekucindazelekeni Kanye nendlela ekwenzeka ngayo i-cellular metabolic ngaphakathi kuma- 
hepatocellular carcinoma (HepG2) seli omuntu. 
Sekungqanyiswe ngokusobala ukuthi ama-mitochondria awumgodlagodla omukhulu ka-ROS Kanye 
nama-DAMPs lawa avusa i-inflamatory response ngosizo luka NLRP3. I- inflammation yafuthi noma 
imvuselelo e-aberrantly regulated iphelela kwimiphumela e- pathological. Kodwa ke, uhlungo 
olukhethekileyo lama-dysfunctional mitochondria nge- autophangy ingangcina i-homeostasis ye-
mitochondria iphinde ivikele kwi- hyperinflammation eqalwa u-ROS Kanye nama-DAMPs. Igalelo lika-
FA (25, 50, 104, and 150 μg/mL, amahora awu 24) kwi IL-1β processing, NRLP3 inflammasome priming 
and activation Kanye-Kanye ne-potential ka-FA yokuqalisa i-anti-inflammatory kanye nama- 
cytoprotective responses nge mitophagy liphenyiwe. U-Fusaric acid uphazamise i-synthesis nokukhula 
kuka- IL-1β ngokucindazela u-NRLP3 priming and activation. I-activation ka-NF-κB, umulawuli owu-
master kuma-inflammatory responses, wacindezelwa ngu-FA nge- downregulation ye-upstream activator 
regulators - IKKβ, TRAF6, IRAK1 and IRAK4. I- experimentation enzulu yaveza i-up-regulation of 
NRF2 kanye ne-concominent elevation ye- antioxidant enzyme SOD2 kanye ne-autophagy/mitophagy 
markers okukhombisa ukuthi u- FA uqalisa uhlelo lwe-NRF2 cytoprotective Kanye nokususwa kwama-
mitochondria a- damaged kumaseli. Lemiphumela ilethe ulwazi kuma-novel mechanism e-immune 
dysregulation ebangwa ngu-FA. 
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Ukuzivumelanisa nezimo kwe-metabolic ikona okucacisa umthamo weseli ekuzinakekeleni kuzinguquko 
kwi-status zezakhi. Ama-mitochondria ibona abahleli ababalulekile ekuzivumelaniseni kwe-metabolic 
Kanti i-dysfunction ibandakanyeka nokungazivumelanisi kwe-metabolic Kanye ne-pathology. Ama-
toxins a-foodborne avamise ukuzibeka ukuba angaba nomuthelela kwi-metabolic toxicity. Kwazise, 
igalelo lika-FA kwi-homeostasis yamandla esibindini somuntu (HepG2) esi-cultured icwaningiwe. 
Amaseli e-HepG2 alungele uhlelo lwe-oxidative Kanye ne-glycolytic metabolism aqhathwe nama-range 
amanani ahlukene ka-FA (4, 63 and 250 μg/mL) kumahora awu-6. I-data ihlanganisa i-constitutive 
expression ka-HIF-1α ukuziphendulela ku-FA ecindazela u-pyruvate decarboxylation nge- up-regulation 
ka-PDK-1 kanye ne-phosphorylation ka-Pyruvate Dehydrogenase E1α subunit. Kwabakhona ukulahleka 
kuka-ATP Kanye ne-metabolite shunt uku-lactate umkhiqizo kumaseli ka-HepG2 a-oxidatively poised. 
Lokhu kwaqinisekiswa ukunyuka kokuvelela kuka PKM2 kanye no-LDHa ngaphezukwalokho, i-
potential ka-FA ukuqala i-glucose “addiction”. 
Kanye ne-phenotype reminiscent ye-Warburg effect iveziwe kafushane. Lemiphumela inikeza ulwazi 
olunzulu ngegalelo lale-foodborne mycotoxin enganakiwe kwi-dysregulation yamandla e-metabolism. 
I-Fusaric acid iyi-compound ehlobene ne-niacin kuphinde nje sekwafakaziswa ukuthi i-chelator ama-
divalent cations. Le-mycotoxin iyi-putative mitochondrial toxin phinde isukele ukuqala kuka-oxidative 
stress. Ama-Mitochondrial sirtuins angama-deacetylases angaphansi kwa-NAD phinde adlala igalelo 
elibaluleke kakhulu kwi-cytoprotection ngokumelene ne- oxidative Kanye ne-mitochondrial stressors 
phinde futhi igcine ukuzivumelanisa nezimo ze- metabolic. Igalelo lika-FA kwi-dysfunction ka-
mitochondrial SIRTs (3 and 5) laphenywa kulesi-study. I-molecular docking iveze i-ligand affinity eqinile 
ka-FA kubona bonke o- SIRTs be-mitochondria, kodwa ke u-SIRT3 iwona otshengise izinga eliphezulu 
le-binding affinity. Imiphumela itshengisa ukuthi u-FA uya-bind kwindawo e-active ka-SIRT3 avimbe i- 
binding ka-NAD (co-factor). Bonke o-SIRT baba-down regulated kwizinga le-protein kodwa batshengisa 
ukunyuka ngezinga kwi-mRNA expression. I-expression profile yama- transcription factor ajwayelekile, 
PGC-1α atshengise i-induction enamandla kwizinga lama protein okusho ukuthi u-FA u-affect inhlelo 
zika-SIRT translation. I-status se- phosphorylation ka eif2α (an indicator of translational inhibition) 
sikhuphukile. Kuphinde nje, i-expression profile ka miRNA 30c, ekuyiyo ecindazela i-SIRT translation 
yanyuka ngezinga eli-significantly. Lesi-study siveza ukuthi u-FA ucindezela ama-activity ka-SIRT; 
phinde futhi le-mycotoxin i-hinder i-SIRT expression ngokuthi i-interfere kwinhlelo ze- translational 
naze-transcriptional phinde ivimbe ukususwa kwama-zinc ions njengoba kudingeka ukugcina i-stability 
sika-SIRT. Ukuvala nje, u-FA ulawula ama-cytoprotective mechanisms aqalwe i-mitochondrial stress 
kwazise lezinhlelo zi-perturb i-cellular homeostasis eholela kuma-aberrant inflammatory processes Kanye 
namandla emetabolism. Ama-toxins a-foodborne anomthelela kwi- mitochondrial toxicity futhi 
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anomthelela kwizimo zezifo ezinjengo mdlavuza Kanye nezifo sikashukela okuyisisuka nge-oxidative 


























1. Introduction  
1.1. Background  
Toxigenic fungi parasitise agricultural commodities and produce a plethora of mycotoxins (Pitt, 2000, 
Tournas and Niazi, 2018). Chronic and acute exposure to these secondary metabolites is often associated 
with adverse outcomes in animals and humans (Zain, 2011). Mycotoxin research interest increased 
following the discovery of aflatoxin B1 (AFB1) as the aetiological agent of Turkey X disease (Bradburn et 
al., 1994, Spensley, 1963). Ensuring feed and food security has significant implications for health and 
economic development, particularly in Africa where environmental factors contribute to accelerated 
fungal growth and mycotoxin production (Wagacha and Muthomi, 2008, Udomkun et al., 2017).  
From an African perspective, Aspergillus and Fusarium-derived aflatoxins and fumonisins, are of major 
concern. These two classes of mycotoxins are wide spread in dietary staples, particularly maize 
(Fandohan et al., 2003, Bankole et al., 2006, Wagacha and Muthomi, 2008). Recently, there is a growing 
interest in the potential toxicity of fusariotoxins (secondary toxic metabolites produced by Fusarium 
species) (Nedělník, 2002). An often neglected fusariotoxin is fusaric acid (FA, 5-butylpicolinic acid). 
This highly ubiquitous toxin is an established phytotoxin (Löffler and Mouris, 1992, Venter and Steyn, 
1998, Wu et al., 2008, Stipanovic et al., 2011a) but was considered to be of moderate toxicity in mammals 
(Wang and Ng, 1999). Fusaric acid exhibits pharmacological effects on the cardiovascular, nervous and 
immune systems (Wang and Ng, 1999). The toxic effects of FA in combination with co-produced, better-
known mycotoxins have revealed synergistic and additive effects in animal models (Bacon et al., 1995, 
Smith et al., 1997, Fairchild et al., 2005). However, studies focusing on single toxin analysis are more 
suited to the correlation of exposure and toxic outcomes.  
The canonical mechanism of FA toxicity is associated with oxidative stress through excessive reactive 
oxygen species (ROS) production and depletion of intrinsic antioxidant systems (Kuźniak, 2001, Hirai et 
al., 2005, Singh and Upadhyay, 2014, Devnarain et al., 2017). Fusaric acid is an efficient chelator of 
divalent cations and subsequent inactivation of metalloenzymes (Stack Jr et al., 2004, Yin et al., 2015). 
Recently, FA was shown to induce DNA damage (Ghazi et al., 2017) as well as aberrant signalling 
cascades and cell death in several human cell lines (Dhani et al., 2017, Devnarain et al., 2017).  
Fusaric acid is a putative mitochondrial toxin, which decreases adenosine triphosphate (ATP) levels in 
plant and animal models (D'Alton and Etherton, 1984, Telles-Pupulin et al., 1998, Pavlovkin et al., 2004, 
Singh and Upadhyay, 2014, Abdul et al., 2016). However, knowledge on the molecular mechanisms 
 2 
 
underlying this mitochondrial dysfunction is lacking. The effect of FA on hepatic energy metabolism was 
assessed in rat liver mitochondria (Telles-Pupulin et al., 1998) and an in vitro human liver model (Abdul 
et al., 2016). Fusaric acid inhibited the activity of key tricarboxylic acid (TCA) cycle enzymes and 
oxidative phosphorylation (Telles-Pupulin et al., 1998). Further, FA induced mitochondrial stress via 
downregulation of key mitochondrial stress response proteins as well as inhibited mitochondrial 
biogenesis (Abdul et al., 2016).  
Mitochondria regulate and maintain several aspects of cell homeostasis, including energy substrate flux, 
apoptosis, inflammation and cell signalling. Mitochondrial dysfunction is associated with pathogenesis of 
cancer and insulin resistance through aberrant metabolic programming (Modica-Napolitano and Singh, 
2004, Singh, 2004, Kim et al., 2008, Sorrentino et al., 2018).  
Studies have revealed the importance of mitochondria in coping with cellular stressors. Mitochondrial 
stress responses including the mitochondrial unfolded protein response (UPR
mt
), antioxidant defences, 
and mitophagy are induced to maintain cellular integrity and organism homeostasis (Kanamaru et al., 
2012, Lin et al., 2018). The sirtuin (SIRT) family of nicotinamide adenine dinucleotide (NAD) dependent 
enzymes is strongly linked to mitochondrial stress responses (Kumar and Lombard, 2015, Lin et al., 
2018). Post translational modifications (PTMs), such as lysine acetylation, ADP ribosylation, 
malonylation, glutarylation, and succinylation on various mitochondrial proteins has emerged as a 
mechanism to fine tune mitochondrial responses. These modifications are directly regulated by members 
of the SIRT family. Recent studies in SIRT biology have uncovered their key roles in regulating multiple 
mitochondrial pathways and dysregulation is often associated with aberrant metabolic homeostasis and 
disease initiation and progression (Ahuja et al., 2007, Lombard et al., 2007, Du et al., 2011, Kumar and 
Lombard, 2015). 
Compromised mitochondria are recognised arbitrators for the pro-inflammatory response. They act by 
controlling innate immunity via ROS sensitive inflammatory pathways and activation of nuclear factor κB 
(NFκB) (García-Ruiz et al., 1995, Amma et al., 2005) or direct priming and activation of inflammasomes 
(Zhou et al., 2011, Nakahira et al., 2011, Won et al., 2015). These pathways often work together to 
process and activate pro-inflammatory cytokines necessary to mount an immune response (López-
Armada et al., 2013).   
The inflammasome is a multi-protein complex that is activated by caspase 1 and subsequently cleaves 
pro-interleukin 1β (IL-1β) into its biologically active form (Franchi et al., 2009, López-Armada et al., 
2013). Recent studies have highlighted mitochondria as important and direct activators of the nucleotide-
binding oligomerization domain like receptor protein 3 (NLRP3) through ROS and damage associated 
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molecular pattern (DAMP) generation (Zhou et al., 2011, Nakahira et al., 2011, Kepp et al., 2011, 
Tschopp, 2011). The NLRP3 inflammasome has been implicated in several pathologic states (Menu and 
Vince, 2011, Vandanmagsar et al., 2011, Wen et al., 2012) and is becoming the subject of intense 
research. Indeed, substantial evidence supports mitochondrial dysfunction and the development of an 
inflammatory phenotype. Mitophagy (removal of damaged mitochondria via autophagy) can prevent and 
control inflammasome activation by preventing ROS and DAMPs accumulation (Goldman et al., 2010, 
Nakahira et al., 2011, Kim et al., 2016).  
Mitochondria are hubs of metabolism that interlink several biochemical processes for efficient energy 
substrate utilisation(Houten and Wanders, 2010, Cheng and Ristow, 2013, Liesa and Shirihai, 2013). This 
makes these organelles integral regulators of metabolic flexibility (capacity to switch between energy 
substrates) (Gao et al., 2014). The metabolic program is an active regulator of cell phenotype and changes 
to the metabolic program results in aberrant energy substrate regulation (Metallo and Vander Heiden, 
2010). Mitochondrial dysfunction is strongly linked to metabolic inflexibility. The pathologic potential of 
metabolic inflexibility is seen in diabetes and insulin resistance (Galgani et al., 2008, Corpeleijn et al., 
2009), while a metabolic switch from mitochondrial oxidative phosphorylation (OxPhos) to aerobic 
glycolysis (Warburg effect) is strongly associated with a cancer cell phenotype and aberrant proliferation 
(Seyfried and Shelton, 2010, Liberti and Locasale, 2016).  
Dietary bioactive compounds are known to have profound therapeutic effects by mitigating inflammation 
and metabolic inflexibility (Kris-Etherton et al., 2004, Serrano et al., 2016, Souilem et al., 2017), however 
very little is known regarding common foodborne toxins and their roles in inflammation and metabolic 
disease initiation and progression. 
1.1.1. Problem statement  
 
The majority of the South African population relies heavily on maize as part of their staple diet. Fusarium 
species parasitise agricultural commodities especially maize and are known producers of FA (Bacon et 
al., 1996). This toxin is highly prevalent, with levels of up to 13,593 µg/kg sample maize being reported 
in the literature (Streit et al., 2013). Although oxidative stress and inhibition of metalloenzymes are 
canonical mechanisms of FA toxicity, little work has been done to explore the mitotoxic potential of FA 





 1.1.2. Hypothesis 
 
It was hypothesised that FA induced mitochondrial stress that is associated with aberrant inflammatory 
responses and metabolic flexibility in addition to energy substrate regulation.  
1.1.3. Aim and Research questions 
 
This study aimed to determine the mitotoxic effects of FA and subsequent dysregulation of molecular 
pathways related to inflammation and energy substrate utilisation in a human liver cell line. The following 
research questions were posed: 
 Does FA induce mitochondrial stress? 
 Is FA involved in the dysregulation of the NLRP3 inflammatory response? 
 Does FA bring about metabolic inflexibility and aberrant energy processing? 
 Can FA disrupt mitochondrial protein PTMs?  
1.1.4. Objectives  
 
The mitotoxic effects of FA in human hepatoma (HepG2) cells were investigated by measuring 
mitochondrial output and determining cellular adaptations to mitochondrial dysfunction. Several aspects 
of inflammation and metabolic flexibility in addition to the molecular mechanisms involved were 
examined. The specific objectives of the study were to investigate the effects of FA on: 
 Mitochondrial stress and biogenesis and its implications on cell death and oxidative stress. 
 The role of mitochondrial dysfunction and release of DAMPs in the priming and activation of the 
NLRP3 inflammasome. . 
  Cytoprotective responses, specifically mitophagy and antioxidant stress responses.  
 Metabolic flexibility and utilisation of energy substrates.  
 Mitochondrial mediators (SIRTs) of PTMs 
1.1.5. Experimental approach  
 
Primary human hepatocytes (PHH) are regarded as the benchmark for toxicity studies due to their 
physiologic similarities to liver tissue. However, isolation from whole livers unsuitable for transplant or 
from healthy sections after surgery can damage cellular contents and membranes (Guillouzo, 1998, 
Guguen-Guillouzo and Guillouzo, 2010). Furthermore, inter-variability between donors, loss of 
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phenotype and scarcity of donors limit the use of PHH for toxicity studies (Heslop et al., 2017). 
Therefore, the use of hepatoma derived cell lines such as HepG2 is often preferred as they offer the 
advantage of homogenous cell populations and unlimited sub-cultivation potential.  
The HepG2 cell line has been extensively used in toxicity studies (Westerink and Schoonen, 2007, Kim et 
al., 2009, Gerets et al., 2012, Ramirez et al., 2018), but it is important to consider the bioenergetic 
phenotype of cells when studying mitochondrial and metabolic effects of toxins. The HepG2 cell line 
originated from the hepatocellular carcinoma of a 15 year old Caucasian male (ATCC), and as such 
anaerobic metabolism and glycolysis predominate energy metabolism due to the Warburg and Crabtree 
effects (Dell’Antone, 2012). Consequently, cell lines originating from tumours are more resistant to 
mitochondrial toxins. By substituting galactose for glucose in cell culture media, HepG2 cells become 
aerobically poised and are forced to undergo OxPhos to maintain ATP levels (Figure 1.1). This 
bioenergetic modification has been reported to sensitise cells to mitochondrial toxins and identify 
compounds that induce mitochondrial dysfunction (Marroquin et al., 2007, Kamalian et al., 2015, Plecitá-
Hlavatá et al., 2015).  Consistent with this methodology, chapters 3 and 4 sought to determine the 
underlying molecular mechanisms of FA on energy metabolism and mitochondrial SIRTs dysfunction in 










Figure 1.1: Glucose metabolism to pyruvate via glycolysis yields a net gain of 2 ATP. The metabolism of 
galactose to pyruvate is inefficient and no substantive ATP is produced. Substituting galactose for glucose 
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forces cells to undergo to use the TCA cycle and OxPhos to maintain ATP levels. Figure adapted from 
(Ostergaard et al., 2007).  
1.2. Literature Review  
 
1.2.1. Food security and mycotoxins  
 
The Food and Agriculture Organization (FAO) defines food security as a ‘‘situation that exists when all 
people, at all times, have physical, social, and economic access to sufficient, safe, and nutritious food that 
meets their dietary needs and food preferences for an active and healthy life’’ (FAO, 2014). Developing 
countries, particularly those in Africa are faced with a multitude of socio-economic struggles making it 
one of the most food insecure regions in the world. Efforts to improve food security in developing 
countries such as South Africa, must aim to expand regulatory structures for safe consumption and 
alleviate poverty through trade of food products that meet stringent international standards (Udomkun et 
al., 2017, Ferrão et al., 2017).   
Enhanced food security is often considered vital to improving health and nutrition status of a country 
through reducing incidents of food and waterborne diseases. Mycotoxins pose a serious threat to food 
security. It is estimated that about a quarter of the world’s agricultural produce is contaminated with these 
ubiquitous toxins (Outlook, 2015). This is of particular concern to South Africa where many low income 
consumers rely on staple diets and traditional food processing that are highly susceptible to mycotoxin 
contamination (Shephard et al., 2002, Odhav and Naicker, 2002, Isaacson, 2005, Shephard et al., 2005) 
and can be linked to aetiology of cancer particularly in rural populations (Sydenham et al., 1990, 
Isaacson, 2005).  
1.2.2. Mycotoxins 
 
1.2.2.1. Mycotoxin overview  
 
Mycotoxins are secondary metabolites of filamentous fungi which parasitise agricultural commodities 
especially grain and wheat (Figure 1.2). One species of fungi is capable of producing a plethora of 
mycotoxins and one type of mycotoxin can be produced by several fungal species, (Pitt et al., 2000, Pitt, 
2000, Hussein and Brasel, 2001), suggesting that co-production and contamination by several mycotoxins 
is highly probable. The fungal species belonging to the Aspergillus and Fusarium genera are considered 
the most important to Africa (Fandohan et al., 2003, Bankole et al., 2006, Wagacha and Muthomi, 2008). 
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The severity of contamination is linked to environmental factors as well as pre-harvest and post-harvest 
(storage of commodities) conditions which contribute to fungal growth and mycotoxin contamination 
(Magan et al., 2003, Chulze, 2010, Magan et al., 2011, Bernhoft et al., 2012). Furthermore, mycotoxins 
are not completely removed by food processing and can be found as contaminants in finished food 








Figure 1.2: Scheme of fungal contamination and mycotoxin production in maize destined for 
consumption in South Africa. Image adapted from (AgTag, 2015). 
The contamination of agricultural commodities by mycotoxins is a global problem (Wild and Gong, 
2009). A highly concentrated and inhomogeneous distribution of a toxin can spoil an entire batch of crops 
(Rivas Casado et al., 2009). This is of particular concern given the open and international trade of food 
and feed. Such massive import and export of agricultural commodities requires stringent guidelines and 
regulatory measures. Legislation exists for metabolites regarded as “regulated toxins” and mycotoxins 
with guidance levels. These two categories include the aflatoxins, some type A and B trichothecenes, 
zearalenone (ZEN), fumonisins and ochratoxin A (OTA), due to their established acute and chronic 
toxicity; values specified in feed are either maximum allowed levels or guidance values (Kovalsky et al., 
2016).  
In the European Union, differences in food/feed commodity, degree of processing (e.g., maize, finished 
feed) and intended consumers (e.g., animal feed) lead to variable maximum allowable concentrations. 
Lowest levels are in place for aflatoxin with a maximum limit of 20 µg kg
-1
. Fumonisin levels in animal 
feed have a set guidance level of 60 mg kg
-1
, but with lower values for pigs, poultry and young animals. 
Guidance values for deoxynivalenol (DON) (0.9–12 mg kg-1), ZEN (0.1–2 mg kg-1) and OTA (0.1–0.25 
mg kg
-1
) are significantly lower. The upper level provides a general value with exceptions applying for 
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animals showing high sensitivity. Lowest values are typically established for swine, poultry and young 
animals. Recommended values for the sum of T-2 and HT-2 toxins are lowest with 250 µg kg
-1
 for 
compound feed, 500 µg kg
-1
 for cereal products and 2,000 µg kg
-1
 for oat milling products (Kovalsky et 
al., 2016).  
The analysis of worldwide mycotoxin occurrence data is of interest, as it can identify geographical areas, 
which are highly contaminated due to climate change or conditions that influence contamination rates. 
This can affect international trade of agricultural commodities (Paterson and Lima, 2010, Magan et al., 
2011).  
1.2.2.2. Mycotoxin toxicity and their biological effects  
 
Exposure to mycotoxins induces numerous acute and chronic effects in animals and humans, such as 
genotoxicity, hepatotoxicity, nephrotoxicity, immunosuppression and teratogenic effects (Veselý and 
Vesela, 1995, Peraica et al., 1999, Hussein and Brasel, 2001). These toxic metabolites are established 
potent mutagens and carcinogens in human and animal models (Sydenham et al., 1990, Gelderblom et al., 
1988, Chuturgoon et al., 2014b, Chawanthayatham et al., 2017). Strong correlations can be drawn 
between carcinogenesis and mycotoxin adducts with DNA. Aflatoxin B1 (AFB1) and its derivatives bind 
covalently to DNA and often cause mutations leading to cancer (Weng et al., 2017). Fumonisin B1 (FB1), 
a common fusariotoxin, may lead to liver cancer through interference with sphingolipid metabolism 
(Garcia-Ruiz et al., 2015, Burger et al., 2018). Recent studies by Chuturgoon et al have highlighted DNA 
modifications, inhibition of apoptosis and epigenetic aberrations favouring cancer phenotypes 
(Chuturgoon et al., 2014b, Chuturgoon et al., 2014a, Chuturgoon et al., 2015). Mycotoxins dysregulate 
protein synthesis by inhibiting translation (Bin-Umer et al., 2014) and up-regulating micro-RNAs 
(miRNAs) that degrade target mRNA preventing translation (Bin-Umer et al., 2014, Chuturgoon et al., 
2014b).   
Oxidative stress – a phenomenon classified by excessive generation of free radicals, is a common and 
plausible mechanism for general mycotoxin toxicity. Oxidative stress causes DNA damage, oxidation of 
macromolecules and cell death (Da Silva et al., 2018). Intracellular antioxidants prevent damage to 
cellular components as a result of oxidative stress. Patulin, a mycotoxin found on apples and some grains, 
has a strong affinity for sulfhydryl groups, especially glutathione (GSH) – an intracellular antioxidant (Jin 
et al., 2016). Several studies have indicated that mycotoxins dysregulate antioxidant responses through 
aberrant control of nuclear factor erythroid 2-related factor 2 (NRF2) (Da Silva et al., 2018), a crucial 
transcription factor for antioxidant enzymes (Liufang et al., 2016).  
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Mitochondria are major sites of ROS production due to electron leakage from the electron transport chain 
(ETC) (Sullivan and Chandel, 2014, Zorov et al., 2014). Mycotoxins contribute to excessive ROS 
production by inhibiting mitochondrial function and consequently damaging mitochondrial DNA. The 
mitochondrial alterations associated with mycotoxin toxicity is the uncoupling of OxPhos, induction of 
mitochondrial permeability and inhibition of mitochondrial stress response proteins (Abdul et al., 2016, 
Da Silva et al., 2018) resulting in decreased ATP synthesis. Mitochondrial dysfunction is linked to 
inflammation which can be attributed to the activation of NF-κB and transcription of inflammatory genes 
(Kastl et al., 2014). Several mycotoxins can modulate the inflammatory response by activating or 
inhibiting NF-κB signalling (Tsai et al., 2016, Adesso et al., 2017, Da Silva et al., 2018).  
The variable molecular structures of mycotoxins account for their wide range of toxic mechanisms of 
action. Fungal secondary metabolites can cause adverse health effects in many whole organ systems. 
Literature on mycotoxin-related human diseases reveals strong correlation between ingesting mycotoxin-
contaminated food and illness, especially hepatic, gastrointestinal, renal, hormonal and carcinogenic 
diseases (Peraica et al., 1999, Fung and Clark, 2004). A summary of the toxic effects of mycotoxins is 









Figure 1.3: Mycotoxins exert a variety of biological activities and inhibit various cellular processes in 





1.2.2.3. Emerging mycotoxins  
 
A multitude of fungal metabolites in food and feed can now be identified and measured with modern 
analytical techniques (Streit et al., 2013, Gruber-Dorninger et al., 2018). In addition to the extensively 
studied and established mycotoxins, emerging mycotoxins are shown to occur ubiquitously in agricultural 
produce (Meca et al., 2010, Zinedine et al., 2011, Vaclavikova et al., 2013). Emerging mycotoxins are 
defined as “mycotoxins, which are neither routinely determined, nor legislatively regulated; however, the 
evidence of their incidence is rapidly increasing” (Vaclavikova et al., 2013, Gruber-Dorninger et al., 
2016). Under this definition, several fungal metabolites with suspected toxicity would fall under the 
category of emerging mycotoxins. The use of liquid chromatography tandem mass spectrometry (LC–
MS/MS) provides new insights into the structure and chemical classification of these novel toxins. Risk 
assessments are underway should legislature regarding regulation of these emerging mycotoxins need to 
be implemented (Vaclavikova et al., 2013).     
Many of these newly discovered secondary metabolites are irrelevant to food and feed safety, but the 
occurrence data collected on a large scale, prior to the assessment of toxicity, can lead to “active” 
research rather than “reactive” research. This can contribute greatly to avoiding catastrophic outbreaks as 
was the case with Turkey X disease. While it is imperative to assess both occurrence and toxicity to draw 
up holistic risk assessments, the need to prioritise research of highly ubiquitous toxins (Figure 1.4) over 






Figure 1.4: Feed contaminated with mycotoxins sensitised scientists to the possibility that these 
secondary metabolites might be deadly to organisms. This increased active research into mycotoxins. 




1.2.3. Fusaric acid  
 
Fusaric acid is one of the most widely distributed fusariotoxins, produced by several Fusarium species 
including F. fujikuroi, F. oxysporum, F. moniliforme, F. subglutinans, F. verticillioides, F. crookwellense, 
F. napiforme and F. proliferatum. A study by Bacon et al. (1996) estimated that 11,665 species of plants 
(hundreds of which are agriculturally important) may serve as hosts of Fusarium spp, suggesting that 
human exposure and contact with FA is considerably high  (Bacon et al., 1996). Occurrence data for FA 
suggest that this mycotoxin is a common contaminant of maize (Bacon et al., 1996, Streit et al., 2013) 
with an average and maximum of 643 and 13,593 µg/kg sample, respectively (Streit et al., 2013).  
Fusaric acid is a polyketide derived secondary metabolite (Brown et al., 2015) and is formed from a 
polyacetate unit and aspartic acid or closely related metabolites (Hill et al., 1966, Stipanovic et al., 
2011b). A study investigating the biosynthesis of FA used 
13
C-labeled substrates such as [1, 2-
13 
C2] 




N-labelled aspartate and [
15
N] glutamine. The integration of labelled 
substrates is consistent with the biosynthesis of FA from three acetate units at C5-C6, C7-C8, and C9-
C10, the remaining carbons are derived from aspartate via oxaloacetate and the TCA cycle. Furthermore, 
this study proved that the nitrogen in FA is derived from an endogenous pool to which both glutamine 
and aspartate contribute, with the former making a larger contribution (Stipanovic et al., 2011b). 
Fundamentally, FA is classified as a pyridine derivative and is a niacin (nicotinamide, NAM) related 
compound. Fusaric acid is made up of a pyridine ring and a butyl group at position C5 (Stack et al., 2014) 
and bares structural similarities to its parent compound, picolinic acid (PA) (Figure 1.5)  (Ogata et al., 
2001). Picolinic acid (PA) is synthesised endogenously by the liver, kidney and brain (Grant et al., 2009); 
PA is produced in a side pathway of NAD biosynthesis in animals (Ogata et al., 2001). Tryptophan can be 
metabolised via the kyneurinine pathway which oxidatively degrades this amino acid to yield kynurenic 
acid, PA and NAD (Figure 1.6) (Grant et al., 2009). Picolinic acid is also produced as a toxin by the 
mould species Magnorpathegrisea and Fusarium spp contributing to their pathogenesis (Zhang et al., 
2004). Structural similarities to biologically relevant molecules contributes significantly to mycotoxin 
mechanisms of action and toxicity (Zain, 2011). Similarities between FA, PA and niacin are depicted in 


























Figure 1.6: Structures of FA (A), PA (B) and NAM (C). All three molecules contain pyridine rings 





1.2.3.1. Pharmacological use of FA 
 
Fusaric acid is the precursor of the beta blocker, bupicomide (Velasco et al., 1975); FA potently inhibits 
dopamine-β-hydroxylase (DBH, catalyses the conversion of dopamine to norepinephrine) in plasma 
causing endogenous norepinephrine levels to drop significantly and was considered a unique, hypotensive 
drug (Terasawa and Kameyama, 1971, Matta and Wooten, 1973). The long term hemodynamic effect of 
an FA calcium salt in 10 elderly hypertensive patients showed that in the first year both the systolic and 
diastolic blood pressures were lowered, with no apparent adverse effects. There were no consistent 
changes in heart rate or plasma volume. It was concluded that the hypotensive response was attained by 
reduction of the total peripheral vascular resistance index (Terasawa et al., 1976). A study in rabbits 
showed that FA can induce relaxation of isolated arterial preparations, likely through chelation of calcium 
(Hidaka and Asano, 1976).  
The effects of FA on DBH extend to the nervous system where it affects neurotransmitter levels. 
Experiments in a geriatric patient population showed FA improved the mental state of patients already on 
neuroleptics. Furthermore, FA significantly relieved oro-facial dyskinesia, tremor, and rigidity (Viukari 
and Linnoila, 1977). The effects of FA on thyroid stimulating hormone (TSH) were clearly demonstrated 
in patients with hypothyroidism. Alterations in brain dopamine, epinephrine and norepinephrine (neuro 
amines) may directly or indirectly suppress pituitary TSH secretion (Yoshimura et al., 1977).   The use of 
FA as a treatment for Parkinson’s disease due to its DBH inhibitory activity has also been proposed but 
not fully explored (Matta and Wooten, 1973). These very early studies highlighted the bio-activity of FA 
in humans.  
In more recent studies FA was shown to be a promising tumoricidal agent in several in vitro models. 
Work by Stack Jr et al. (2004) presented FA as a potential therapeutic agent for targeting head and neck 
squamous cell cancer. Many metalloproteins are involved in DNA repair and promotion of on-going cell 
growth and proliferation, chelation may be an alternate means of inducing cell cycle arrest or apoptosis. 
The potential anti-tumour action of FA may be brought on in part by its ability to chelate divalent cations 
from metalloproteins such as metallopanstimulin-1, which is a zinc finger protein involved in DNA repair 
and protein synthesis (Stack Jr et al., 2004).  
Ruda et al. (2006) demonstrated that oral administration of FA inhibits tumour growth in an animal 
model. Following tumour cell inoculation mice were treated with FA or saline. This study revealed that 
mice treated with FA had considerably slower tumour growth rates as well as reduced tumour mass when 
compared to control mice. This suggests a suppressive effect of FA on head and neck squamous cell 
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cancer xenografts (Ruda et al., 2006). Consequently, experiments with FA in combination with two of the 
most currently used chemotherapeutic agents - paclitaxel and carboplatin showed better efficacy and 
tumoricidal potential than when these drugs were used as single agents. Data from this study suggested 
that these combinations may provide an improved anti-tumour effect. This type of adjuvant therapy was 
touted as being a paradigm change in chemotherapy (Jaglowski and Stack Jr, 2006, Ye et al., 2013).  
1.2.3.2.  Toxicity of Fusaric Acid  
1.2.3.2.1. Plant toxicity  
 
The phytotoxic potential of FA is well established as it has been identified as the causal agent of wilt 
disease (Gaumann, 1957, Toyoda et al., 1991, Bacon et al., 1996). Fusaric acid accelerates the 
development of wilt disease by causing non-stomatal water loss as a result of membrane damage to leaf 
cells (Wang et al., 2015a). This phytotoxin inhibits photosynthesis by reducing chlorophyll mass and 
inducing cellular necrosis in leaves (Wu et al., 2008). Experiments by Diniz and Oliveira showed that the 
development of corn seedlings is adversely affected by FA.  Fusaric acid  interferes with energy 
metabolism, thus inhibiting the ATP dependent process of root hair elongation (Diniz and Oliveira, 2009). 
It is plausible that FA is a putative mitochondrial toxin as it impairs the flow of electrons between 
succinate dehydrogenase and coenzyme Q, inhibits : (1) ATPase/ATP-synthase activity, (2) α-
ketoglutarate dehydrogenase (Telles-Pupulin et al., 1996) and (3) some metalloenzymes (e.g., cytochrome 
oxidase) leading to respiratory impairment (Singh and Upadhyay, 2014). Mitochondrial dysfunction is 
necessary for the programmed cell death observed in cells treated with FA. These cells exhibit a loss in 
mitochondrial membrane potential, depleted ATP content and antioxidant activities as well as elevated 
levels of hydrogen peroxide (H2O2) and lipid peroxidation (LPO) (Samadi and Behboodi, 2006, Jiao et al., 
2014, Singh and Upadhyay, 2014).   
1.2.3.2.2. Animal Toxicity  
 
Since FA is considered moderately toxic, its effects in animals and mechanisms of toxicity are not well 
studied. The overall toxicity of FA is grossly underestimated as only a few feed and food products have 
been screened for FA despite its ubiquitous presence (Smith and Sousadias, 1993, Porter et al., 1995, 
Streit et al., 2013). Toxic interactions of FA and FB1, two of the most common mycotoxins produced by 
Fusarium, confirmed in a chicken egg model experiment that FA can enhance toxicity in mammalian 
systems if it is consumed with other mycotoxins (Bacon et al., 1995).  
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Porter and colleagues showed that FA is co-synthesised with other fusariotoxins (Porter et al., 1995) and 
these toxins exhibit synergistic and additive effects. Experiments conducted in immature swine showed 
that by feeding a blend of FA and deoxynivalenol, feed intake and weight gain were drastically decreased 
(Smith et al., 1997, Swamy et al., 2002). Fusariotoxin blends were found to alter neurotransmitter levels 
and brain regional neurochemistry (due to DBH inhibition), thus providing a potential mechanistic basis 
for the feed refusal (Swamy et al., 2002). Chickens and turkeys fed FA-contaminated diets (up to 150 mg 
FA/kg diet), on the other hand, did not show any abnormalities in behaviour, feed intake, weight gain, and 
appearance of visceral organs or lesions (Chu et al., 1993, Fairchild et al., 2005), this suggests that the 
effect of FA is species dependent.  
The immunotoxicity of diets co-contaminated with FA and other fusariotoxins has been verified by 
decreased cell-mediated immunity but enhanced the humoral response in chickens (Chu et al., 1993), and 
elevated  serum immunoglobulin concentrations in pigs (Swamy et al., 2002). Further research is needed 
to determine the aetiology of the elevated serum immunoglobulin concentrations and its subsequent 
pathophysiology.  
Studies focusing on FA alone are likely to show a better correlation between its concentration and 
potential mechanisms of action. It is acknowledged that FA is of relatively low acute toxicity with lethal 
dose (LD50) values in mice of 80 and 100 mg/kg body weight for intra peritoneal and intra venous 
administration respectively. Death caused by the LD50 is believed to be due to the hypotensive effect of 
FA (Hidaka et al., 1969). The bioavailability (25 mg/kg) in Sprague−Dawley rats of FA was calculated to 
be 58% (Stack et al., 2014) while its half-life in human plasma was approximated to be 12 hours (Matta 
and Wooten, 1973).  
Oral dosing of swine with FA had profound changes on behaviour and neurochemistry. Vomiting was 
noted in more than half of the treated animals. The major changes in brain tissue of sacrificed pigs were 
elevated concentrations of tryptophan, 5-hydroxytryptamine and serotonin. Dosed pigs appeared 
lethargic; the authors suggested that lethargy was due to increased serotonin synthesis (Smith and 
MacDonald, 1991).  
An in vivo rat model further confirmed that FA induced neurochemical alterations. Rats were 
administered FA intraperitoneally and showed elevated brain levels of serotonin, 5-hydroxy-indoleacetic 
acid, tyrosine, and dopamine, while norepinephrine was decreased. Dopamine in the pineal gland 
increased with a concomitant decrease to norepinephrine. Pineal N-acetyl-serotonin was increased 
whereas pineal serotonin and its two major metabolites 5-hydroxyindoleacetic acid and 5-
hydroxytryptophol decreased. This was hypothesised to be a result of partial inhibition of tyrosine-
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hydroxylase and DBH by FA (Porter et al., 1995). It is well known that tryptophan is needed for the 
synthesis of neurotransmitters and is a precursor of serotonin. A previous study revealed FA 
administration in rats increased both free circulating tryptophan and tryptophan levels in the brain 
suggesting that FA affects tryptophan disposition. This may occur through two mechanisms as in vivo 
peripheral alterations in catecholaminergic metabolism and by FA chemical structure since in vitro 
experiments showed that FA displaced tryptophan binding to albumin, thus increasing the plasma free 
tryptophan pool (Chaouloff et al., 1986). These studies suggest possible mechanisms for the altered 
neurochemistry induced by FA.   
The embryotoxic and teratogenic effects of FA have been assessed in mice (Reddy et al., 1996) and 
zebrafish (Yin et al., 2015) models respectively. During pregnancy, FA increased the maternal 
corticosterone levels of dams (CD-1 mice) which can lead to cleft palate in the offspring via reduced 
catecholaminergic activity. This may be due to reduced catecholamine synthesis via FA dependent DBH 
inhibition (Reddy et al., 1996). Yin et al. investigated the teratogenicity of FA in zebrafish and found that 
FA caused an undulated notochord in zebrafish development as a result of copper chelation and 
subsequent inhibition of lysyl oxidase (Yin et al., 2015).  
Fusaric acid was measured in colostrum of rat pups and was directly proportional to the amount of FA 
consumed by nursing dams indicating lactational passage of FA. Further FA was found to decrease pineal 
serotonin and tyrosine in nursing pups. The data also suggest limited neonate weight gains may be related 
to either decreased milk production in dams or mycotoxin effects on the neonate (Porter et al., 1996). In 
summary, FA is active in the neurochemical, cardiovascular and reproductive systems, but most in vivo 
data indicate relatively low toxicity.  
1.2.3.2.3. In vitro toxicity   
 
Several in vitro studies have revealed a toxic profile of FA, this coupled with the use of advanced 
molecular techniques, helped elucidate some of its molecular mechanisms of toxicity in human cell 
models. Toxicity data generated from cell viability assays indicate that the effects of FA are cell line 
dependent. Recent studies (on human cancer cell lines) revealed that FA decreased cell viability at higher 
concentrations (24 hrs; IC50 = 78 μg/ml, 107.7 μg/ml and 104 μg/ml for SNO (oesophageal cancer), THP-
1 (leukaemic) and HepG2 (human liver) cells respectively) (Abdul et al., 2016, Devnarain et al., 2017, 
Dhani et al., 2017). These cytotoxicity studies provide evidence that FA can be considered to be toxic in 
humans.   
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Understanding the molecular mechanisms underlying the potential toxicities of FA is paramount to risk 
assessment. The overt production of ROS is often associated with FA toxicity. Elevated levels of 
malondialdehyde (MDA) - a marker for lipid peroxidation and oxidative stress- have been detected in 
human cell lines (Abdul et al., 2016, Dhani et al., 2017, Devnarain et al., 2017). Fusaric acid increased the 
production of ROS through enhancement of the Fenton reaction (Iwahashi et al., 1999, Hirai et al., 2005). 
The nitrogen atom in the pyridine ring and the oxygen atom in the carboxyl group seem to participate in 
the chelation of the Fe
2+
 ion (Figure 1.7) (Hirai et al., 2005) thereby increasing hydroxyl radical 
formation. Fusaric acid induced the expression of NRF2, the key antioxidant transcription factor, 








Figure 1.7: Ferrous iron in complex with FA (Hirai et al., 2005).  
The induction of cell death by FA and its implications for cytotoxicity have been established in several 
human cell lines. Activation of caspase 3 (executioner caspase) was elevated in human liver (Abdul et al., 
2016), oesophageal (Devnarain et al., 2017) monocytic (Dhani et al., 2017) and promyelocytic (Ogata et 
al., 2001) cell lines. Further investigation into apoptosis initiation showed increased caspase 8 and 9 
activities, suggesting that FA is capable of up-regulating both the extrinsic and intrinsic apoptotic 
pathways (Dhani et al., 2017, Devnarain et al., 2017). Mechanistic insights into the induction of caspase 
activation are yet to be fully elucidated. Work by Dhani et al (2017) and Devnarain et al (2017) showed 
that downregulation of anti-apoptotic B-cell lymphoma 2 (Bcl-2) and upregulation of BCL2-Associated X 
Protein (BAX) proteins (Devnarain et al., 2017, Dhani et al., 2017) are common upstream events in 
caspase mediated cell death. Fusaric acid is a genotoxic agent capable of inducing DNA fragmentation in 
HL-60 cells (Ogata et al., 2001). A later study by Ghazi et al (2017) validated the DNA damaging effect 
of FA and proposed that PTMs to the tumour suppressor protein, p53 (the guardian of the genome) leads 
to apoptosis in liver derived cells (Ghazi et al., 2017).  
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Fusaric acid, considered as a putative mitochondrial toxin (Arias, 1985, Telles-Pupulin et al., 1998), is a 
major disruptor of cell energy metabolism. Several in vitro studies have shown FA to dysregulate 
NAD/NADH metabolism and decrease ATP levels in mammalian cells (Telles-Pupulin et al., 1998, 
Abdul et al., 2016, Dhani et al., 2017, Devnarain et al., 2017). Work by Telles-Pupulin et al (1998) has 
demonstrated that FA inhibited succinate-dehydrogenase, α-ketoglutarate-dehydrogenase and OxPhos. 
The inhibition of OxPhos is the result of direct action on the ATP-synthase/ATPase complex without 
significant inhibition of the ATP/ADP exchange in isolated perfused rat liver. Oxygen uptake and 
gluconeogenesis from pyruvate are both inhibited by FA. Although the same enzymes are inhibited in 
maize seedlings, rat mitochondria are more sensitive (Telles-Pupulin et al., 1998). Furthermore, chain 
elongation of FA is catalysed in mitochondria to yield CoA esters of FA with acetyl-CoA utilised as a 
source of C2 (Mizugaki et al., 1986).  
Cells have developed a network of regulated stress-response mechanisms. Fusaric acid was shown to 
abrogate mitochondrial responses to oxidative stress by decreasing the expression of SIRT3 and PGC-1α. 
The accumulation of toxic, oxidised and misfolded mitochondrial proteins can be enhanced by FA via 
down-regulation of LON protease (LON-P) and heat shock protein 70 (HSP70) (Abdul et al., 2016). 
Increased oxidative stress due to mitochondrial dysfunction often enhances mitochondrial biogenesis (Lee 
and Wei, 2005). The process of generating new and functional mitochondria relies on the coordinated 
transcription of nuclear and mitochondrial genes. Fusaric acid downregulated the expression of hepatic 
nuclear respiratory factor 1 (NRF1) and PGC-1α, key co-transcription factors required for expression of 
mitochondrial specific proteins (Abdul et al., 2016). Furthermore LON-P deficient cells switched to 
necrosis as a result of ATP depletion caused by mitochondrial defects (Bota et al., 2005). Lactate 
dehydrogenase (LDH) release was increased by FA- an indication of increased necrotic cell death (Abdul 
et al., 2016, Devnarain et al., 2017). Taken together these studies showed that mitochondrial function and 
biogenesis is impaired by FA and this has implications on cell death and viability. An overview of FA 
















Figure 1.8: Major mechanisms of FA mediated toxicity in cells. Prepared by author.   
1.2.4. Mitochondria 
 
Mitochondria are double membrane organelles that fulfil cellular energy needs through the conversion of 
macromolecules (carbohydrates, fatty acids, and amino acids) into ATP – the energy currency of the cell. 
Therefore, tissues with high metabolic rates like muscles, liver, brain, and heart have the highest density 
of mitochondria (Kakkar and Singh, 2007). These organelles auto-replicate and possess their own genome 
(Jornayvaz and Shulman, 2010). Mitochondrial DNA is circular and encodes 13 mRNAs, 22 tRNAs and 2 
rRNAs. All 13 mRNAs encode proteins necessary for OxPhos. The remaining mitochondrial proteins are 
encoded by the nuclear genome (Yoboue and Devin, 2012). The coordinated synthesis and import of 
proteins encoded by the nuclear genome is required for correct mitochondrial biogenesis  (Jornayvaz and 
Shulman, 2010). Because a major portion of mitochondrial proteins are encoded by nuclear DNA, several 
mechanisms exist to target, import, and correctly assemble these proteins thereby ensuring proper 
mitochondrial function and morphology  (Ventura-Clapier et al., 2008). 
1.2.4.1.  Mitochondria and ATP synthesis  
 
Mitochondria are divided into four compartments: an inner membrane, an outer membrane, a matrix space 
surrounded by the inner membrane, and an inter-membrane space between the outer and inner 
membranes. The TCA cycle occurs in the matrix of the mitochondria and OxPhos occurs on the inner 
membrane (Kakkar and Singh, 2007).  
 20 
 
The TCA cycle is a central pathway that connects several individual metabolic pathways. It is considered 
the most important metabolic pathway for energy supply as it integrates carbohydrate, fatty acid, and 
amino acid metabolism. The TCA cycle is responsible for the production of several intermediates needed 
for anabolic processes as well as NADH and flavin adenine dinucleotide (FADH2) which are fed forward 
into the ETC (Figure 1.9) (Akram, 2014).  
Production of ATP relies on electron transfer at the ETC. This chain is comprised of multi-enzyme 
complexes that are embedded in the inter-mitochondrial membrane: complex I: NADH CoQ reductase, 
complex II: succinate-CoQ reductase, complex III: reduced CoQ cytochrome c reductase, complex IV: 
cytochrome c oxidase and complex V: ATP synthase which is made up of the F1 and F0 units (Kakkar and 
Singh, 2007). 
The ETC generates an electrochemical proton gradient across the inner membrane which drives OxPhos. 
Complex 1 oxidises NADH to NAD
+
 and initiates the process of electron flow. Electrons sequentially 
flow through complex III, cytochrome c and lastly through complex IV where bound oxygen is reduced to 
water. During the process of electron flow from NADH to molecular oxygen, each of the three complexes 
(I, III, and IV) catalyses the translocation of protons across the inner mitochondrial membrane. During 
OxPhos the F0 sub-unit conducts energy from the electrochemical proton gradient to the F1 unit promoting 
ATP synthesis. This gradient facilitates the entry of adenosine diphosphate (ADP) and inorganic 
phosphate (Pi) into the matrix space. The ATP synthase complex then binds ADP to Pi producing ATP 











Figure 1.9: Representation of the various complexes involved in the ETC and OxPhos (Kakkar and 
Singh, 2007).  
1.2.4.2.  Mitochondria and redox signalling  
   
Mitochondria are also involved in redox signalling pathways by fine tuning NAD
+
/NADH redox coupled 
reactions and generating superoxide (O2
-
) together with H2O2 (Yin and Cadenas, 2015). In mitochondria, 
the flow of electrons down the ETC to complex IV results in their deposition onto molecular oxygen to 
form water. However, electrons can also react with oxygen at sites in the ETC to form ROS. Complexes I 
and III are associated with the majority of mitochondrial ROS (mtROS) generation (Shadel and Horvath, 
2015).  
To be effective cell signalling molecules, these oxygen species need to reversibly modify target proteins 
to alter their activity. Generally, this is through modification of a thiol group on a cysteine residue. All of 
these post-translational modifications can potentially act as “redox switches” altering protein function, 
thereby, enabling it to respond appropriately to the reduction potential of a particular redox couple, or to 
the generation of a particular ROS.  However, if an active-site thiol is modified, then the protein loses its 
functionality (Collins et al., 2012, Schulz et al., 2014).  
1.2.4.3.  Mitochondria and cell death  
 
Mitochondria are key regulators of cell death (Liu et al., 2018). Apoptosis is a programmed and 
controlled mechanism that allows for the active removal of damaged and dying cells while allowing 
healthy cells to survive (Henson and Hume, 2006). The mitochondrial permeability transition pore 
(MPTP) which is found at exchange points between the outer and inner mitochondrial membrane, consists 
of a complex made of the voltage dependent anion channel (VDAC), the adenine nucleotide translocase 
and cyclophilin-D (CyP-D) proteins (Baines et al., 2005). Under normal physiological conditions the pore 
is closed, however events such as elevated ROS production and BAX expression can lead to an increase 
in the permeability of the mitochondrial membrane to molecules with a molecular weight less than 
1.5kDa. The subsequent entry of protons into the mitochondria causes expansion of the matrix and 
rupture leading to the release of pro-apoptotic factors, cytochrome c and apoptosis-inducing factor (AIF) 
(Green and Reed, 1998, Harris and Thompson, 2000).  
Caspases are intracellular cysteine proteases that cleave protein substrates after aspartic acid residues and 
are responsible for the distinctive morphological features associated with apoptosis. Cytochrome c release 
is a major trigger for the activation of the mitochondrial (intrinsic) apoptotic pathway (Figure 1.10). Once 
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in the cytoplasm, cytochrome c binds its cytosolic partner apoptotic protease activating factor-1 (Apaf-1), 
and induces the oligomerisation of Apaf-1 cytochrome c complex in a dATP/ATP-dependent manner. 
This multimeric complex known as the apoptosome then recruits the initiator caspase, caspase-9, to the 
complex and induces procaspase-9 activation. The activated caspase-9 then cleaves and activates 
downstream caspases such as caspase-3 and caspase-7 that constitute major caspase activity in apoptotic 
cells (Hu et al., 1999, Jiang and Wang, 2000).  
As apoptosis is an ATP requiring process, should MPTP occur in a small number of cells, sufficient ATP 
will direct the pathway in favour of apoptosis. Conversely, if a majority of cells undergo MPTP opening 
with a concomitant decrease in OxPhos, then necrosis will be the overriding mechanism of cell death. 
Thus, the mechanism of cell death via either apoptosis or necrosis is dependent on mitochondrial function 














Figure 1.10: Generalised schematic for the mitochondrial apoptotic pathway. Adapted from (Li and 
Sheng, 2012).  
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1.2.4.4.  Mitochondria and inflammation  
 
Inflammation is a basic biological response to alleviate invading pathogens and contribute to tissue repair 
and preventing further cell injury (Medzhitov, 2008). Several recent studies have begun to highlight the 
intricate role of mitochondrial dysfunction in inflammatory responses through two established pathways 
(Figure 1.11). Mitochondrial dysfunction may generate low-grade inflammatory responses through ROS 
generation and NF-κB activation (García-Ruiz et al., 1995, Gloire et al., 2006).  
The NLRP3 inflammasome forms cytosolic oligomers with apoptosis-associated speck-like protein 
(ASC) in cells triggering autocatalytic activation of caspase-1.  Caspase-1, in turn, cleaves pro-IL-1β to 
its biologically active form (Bauernfeind et al., 2009, Mankan et al., 2012, Karmakar et al., 2015). The 
NLRP3 inflammasome undergoes bipartite activation (Latz, 2010). Often activation of NF-κB is the first 
signal (signal 1), and is needed for the transcriptional activation of pro-IL-1β and NLRP3. The second 
signal activates the NLRP3 inflammasome. Recently, two studies have reported on the important role for 
mitochondria in NLRP3 inflammasome activation (Nakahira et al., 2011, Zhou et al., 2011). Specifically, 
Zhou et al. (2011) found that mtROS is critical for NLRP3 activation; whereas Nakahira et al. (2011) 
reported that oxidised mitochondrial DNA (mtDNA) plays an important role. Moreover, impairment of 
the ETC with known inhibitors such as rotenone confer a selective priming signal for NLRP3 activation 
(Won et al., 2015).   
Excess ROS drives oxidation of macromolecules, mtDNA is especially vulnerable to oxidative damage 
because of its close proximity to the site of ROS production and lack of protective histones (Bogenhagen, 
2012). Mitochondrial dysfunction drives mitochondrial genome mutagenesis, affecting genes encoding 
ETC complexes and compromising the efficiency of OxPhos, which may lead to further mtDNA 
mutations (Yakes and Van Houten, 1997, Indo et al., 2007) thereby causing a vicious cycle and perpetual 
inflammasome activation.  
An alternative pathway by which defective mitochondria evoke inflammatory responses is by the release 
of their contents into the cytoplasm and/or extracellular environment. DAMPs are macromolecules 
capable of eliciting a strong local inflammatory response, and are released by host cells during severe 
injury induced by infection or stress (Chen and Nuñez, 2010). Generally, depending on the specific 
circumstances, cells can suffer from several stress pathways that promote specific inflammatory responses 
viz DAMP-induced inflammation or sterile inflammation. Taken together mitochondrial dysfunction is 
essential to the development of the inflammatory phenotype (López-Armada et al., 2013).   












Figure 1.11: The interrelation between mitochondrial dysfunction and inflammatory response. Adapted 
from (López-Armada et al., 2013).   
1.2.5. Mitochondrial dysfunction – metabolic diseases  
 
Metabolic dysfunction in common diseases are rarely caused by isolated genetic defects; rather, they 
derive from the interaction of polygenic stimuli and influencing environmental factors resulting in 
impaired metabolism and signs of aberrant cell homeostasis. It comes as no surprise that the regulatory 
networks that govern mitochondrial function also play important roles in several diseases (Galgani et al., 
2008). 
1.2.5.1  Metabolic flexibility and insulin resistance  
 
Metabolic flexibility is the capacity for the organism to adapt fuel oxidation to fuel availability (Galgani 
et al., 2008). Normal energy metabolism requires periodic switching between glucose and fat oxidation by 
the mitochondria to regulate “carbon combustion” of available fuel sources according to physiological 
and nutritional situations. Mitochondria are ideally situated to monitor and sense changes to nutrient 
status throughout the metabolic network and suggests that shifts in energy flux control are integrated a 
executed by functional mitochondria. Intricate metabolic and cell signalling cascades enable coordinated 
transitions between fuel sources to maintain energy homeostasis. Metabolic diseases are now being 
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recognised as disorders of metabolic inflexibility associated with impaired fuel switching and energy 
dysregulation (Muoio, 2014).  
Within the environment of chronic overfeeding, competition between energy substrates is escalated and 
there is persistent oxidation of all major fuels since mitochondria are left in a state of indecision. The 
capacity of mitochondria to switch between fuels is coupled to changes in cellular and/or tissue functions, 
such as insulin action, glucose disposal, lipolysis and lipid storage as well as inflammation (Koves et al., 
2008, Meex et al., 2009, Liu et al., 2012). Aberrant fuel switching and selection precedes and contributes 
to insulin resistance. In vivo rodent models have shown that obesity-induced perturbations in substrate 
switching are evident and metabolic inflexibility is an early event in the course of glucose intolerance 
(Noland et al., 2009, Muoio and Neufer, 2012, Muoio et al., 2012).  
1.2.5.2.  Metabolic aberrations in cancer cells 
 
Aberrant metabolism is a hallmark of cancer cells (Hanahan and Weinberg, 2011). Most cancer cells are 
reliant on aerobic glycolysis; a phenomenon termed the “Warburg effect” (Warburg, 1956). Aerobic 
glycolysis is an inefficient way to produce ATP; however, this type of metabolism is adapted for rapid 
cell growth and division by facilitating the uptake and incorporation of nutrients as building blocks (e.g., 
nucleotides, amino acids, and lipids) needed to produce a new cell (Vander Heiden et al., 2009). 
Originally, defective mitochondria were thought to be the key determinant in facilitating a switch from 
OxPhos to aerobic glycolysis as an adaptive mechanism (Warburg, 1956). However, several recent 
publications have suggested that mitochondria remain functional in cancer cells (Wallace, 2012, Shen et 
al., 2018, Jia et al., 2018, Rinaldi et al., 2018).  
During the development of oncogenesis, cancer cells acquire an adaptive phenotype that is beneficial and 
necessary for cell survival and proliferation (Hanahan and Weinberg, 2011). The classical metabolic 
profile of cancer is increased glucose consumption and lactate production. Under this model the majority 
of glucose undergoes glycolysis to produce two molecules of pyruvate. The pyruvate is then diverted 
from the mitochondrial OxPhos pathway toward lactate production via lactate dehydrogenase A (LDH-A) 
(Olson et al., 2016). Pyruvate can be considered as the link between cytosolic and mitochondrial 
metabolism. Pyruvate is synthesised as the final step of glycolysis by pyruvate kinase (PK). This enzyme 
exists as either the M1 or M2 isoform, with M2 being more prevalent in cancer cells (Demaria and Poli, 
2012, Graziano et al., 2017). Cells with an elevated PKM2/PKM1 ratio can slow the production of 
pyruvate in response to proliferation signals. This phenomenon likely enables the preferential use of 
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glycolytic intermediates for the biosynthesis of cellular building blocks (Anastasiou et al., 2012, Lunt et 
al., 2015).  
In oxidative cells, pyruvate is transported into mitochondria where it is converted to acetyl-coA in the 
mitochondrial matrix by the pyruvate dehydrogenase (PDH) complex. Several lines of evidence suggest 
post-translational regulation of PDH in cancer by inhibitory phosphorylation. PDH kinase 1 (PDK1) 
phosphorylates and inactivates PDH. This kinase is frequently overexpressed in cancer cells and has been 
strongly implicated in oncogenesis (Kikani et al., 2012, Tan et al., 2013, Emmanouilidi and Falasca, 
2017). Acetyl-coA (produced by PDH) is then condensed with oxaloacetate to form citrate using the 
enzyme citrate synthase in the TCA cycle. In some situations, cancer cells produce acetyl-coA from 
scavenged acetate via acetyl-coA synthetase 2 (ACSS2), in order to maintain proliferation during 
metabolic stress (Mashimo et al., 2014, Schug et al., 2015).  
The metabolic inflexibility and glucose reliant nature of cancer cells is considered largely irreversible 
(Olson et al., 2016). Some of these phenotypes, associated with the Warburg effect, are the products of 
altered transcriptional programs brought on by mutations and/or tumour cell environment (Lengauer et 
al., 1998, Harris, 2002, Gatenby and Gillies, 2004).  Hypoxia is recognised as an important feature of 
tumours and plays a fundamental role in several cellular processes. These responses to hypoxia are 
coordinated by activation of the hypoxia-inducible factors (HIFs) that plays critical roles in the adaptation 
of tumour cells to a hypoxic microenvironment (Ruan et al., 2009). Activation of glycolytic genes by 
HIF-1 is important for metabolic adaptation of cancer cells to hypoxia through increased conversion of 
glucose to pyruvate and subsequently to lactate (Figure 1.12). HIF-1 is a heterodimeric transcription 
factor, consisting of HIF-1α and HIF-1β subunits. HIF-1α actively suppresses metabolism at the TCA 
cycle by directly activating the gene encoding PDK1. A hypoxia-induced metabolic switch shunts glucose 
metabolites from the mitochondria to glycolysis to maintain ATP production and prevents toxic ROS 
production (Kim et al., 2006). A summary  
Since Warburg’s initial observations, many of the molecular pathways of how glucose metabolism is 
altered by specific signalling pathways during tumorigenesis have been elucidated, however, foodborne 





















Figure 1.12: Schematic representation of glucose shunting mediated by HIF-1α in cancer cells. Prepared 
by author 
1.2.6. Cytoprotection in response to mitochondrial stress  
 
Mounting appropriate responses to stress conditions are imperative for maintaining a functional 
mitochondrial network. Due to their role in energy metabolism and ATP production, mitochondria are 
exposed to high levels of ROS, making them susceptible to mtDNA mutations and protein miss folding. 
Mitochondria are formed from proteins encoded by both nuclear and mitochondrial genomes; therefore, 
additional regulatory mechanisms are required for the proper coordination of protein synthesis and the 
mitochondrial import of nuclear-encoded proteins. For these reasons, mitochondria have developed 
several systems of quality control to ensure that the number of functional and healthy mitochondria is 
present to meet the demands of the cell. Mitochondrial quality control processes are multi-tiered, 





1.2.6.1.  NRF2 and mitochondrial homeostasis 
 
 The transcription factor NRF2 is the master regulator of cellular redox homeostasis. A large network of 
antioxidant enzymes, proteins involved in cell repair and damage control, xenobiotic detoxification as 
well as anti-inflammation and other transcription factors are regulated at the transcription level by NRF2 
(Holmström et al., 2016). In most cells, mitochondrial OxPhos generates the majority of ROS (St-Pierre 
et al., 2002, Zorov et al., 2014). Several disease states have implicated excess ROS and oxidative stress as 
a common feature (Pham-Huy et al., 2008, Kawagishi and Finkel, 2014). Although traditionally viewed 
as a toxic by-product of respiration, ROS is now being appreciated as a powerful signalling molecule 
(Ray et al., 2012, Zhang et al., 2016).  
Mitochondrial ROS production can be counterbalanced by the activation of NRF2, a cap ‘n’ collar basic 
leucine zipper transcription factor. Under basal conditions, NRF2 is sequestered in the cytoplasm by 
Kelch-like ECH-associated protein 1 (Keap1). This complex directs NRF2 polyubiquitination and 
degradation by functioning as an adaptor of the Cul3 based E3 ligase (Dinkova-Kostova et al., 2005). 
Upon oxidative stress, NRF2 is liberated from Keap1 and enters the nucleus, to stimulate the expression 
of antioxidant response element (ARE) genes (Thimmulappa et al., 2002, Cho et al., 2005).  A study by 
Dinkova-Kostova et al. (2005) determined the kinetics and stoichiometry of Keap1 that regulates its 
susceptibility to oxidant or electrophile mediated modifications. The results revealed that zinc was bound 
to the reactive cysteine thiols of Keap1 and established that inducers displace this metal. Thus, regulation 
of the phase II response involves chemical modification of critical cysteine residues of Keap1, whose 
reactivity is modulated by zinc binding. Keap1 is a zinc-thiol protein enabled with a switch controlled by 
both metal-binding and thiol reactivity. Under non-stressed conditions Keap1 binds zinc that is 
coordinated in part by reactive cysteine residues. In this conformation, Keap1 binds NRF2 and marks the 
transcription factor for degradation. Upon inducer sensing, the zinc is released and the reactive cysteine 
residues are modified by alkylation, oxidation, or thiol-disulphide interchange, leading to a 
conformational change that separates the Kelch domains and releases NRF2 allowing its nuclear 
translocation and enhanced expression of phase 2 response genes (Dinkova-Kostova et al., 2005).  
Reduced glutathione is the primary small molecule antioxidant in the mammalian cell and a product of 
several of the downstream target genes of NRF2. NRF2 regulates the expression of γ-glutamyl cysteine 
ligase catalytic and modulatory subunits, glutathione reductase (Holmström et al., 2016), along with the 
nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) producing enzymes (Chan and Kwong, 
2000) all of which are involved in the biosynthesis and maintenance GSH. Glutathione cycles between 
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reduced and oxidised forms to neutralise H2O2 (Figure 1.13), thus, counterbalancing the production of 
ROS (Holmström et al., 2016). 
 
Figure 1.13: Glutathione cycling in cells. Prepared by author.  
It has been established that the NRF2 pathway is initiated in response to mitochondrial toxins (Calkins et 
al., 2005, Shih et al., 2005) and several mitochondria associated diseases show dysregulation of the NRF2 
pathway (Chen et al., 2009, Tufekci et al., 2011), suggesting an additional role to the detoxification of 
ROS. The mitochondrial membrane potential (Δψm) is considered an indicator of the metabolic state and 
overall mitochondrial health of cells. In a healthy cell, Δψm is maintained by the mitochondrial respiratory 
chain. NRF2 has been shown to activate transcription of the mitochondrial electron transport chain 
component NDUFA4 and down-regulate cytochrome c oxidase subunits COX2 and COX4 (Agyeman et 
al., 2012). The basal Δψm is higher when NRF2 is constitutively up-regulated (Holmström et al., 2013). 
Taken together these studies show that respiration is affected by the activity of NRF2. Mitochondrial 
substrate production is regulated by NRF2 and is considered the most profound way that this transcription 
factor affects mitochondrial function. The NADH redox index within mitochondria (the balance between 
consumption of NADH by complex I and production of NADPH in the TCA cycle) is significantly lower 
in cells showing NRF2 knockout (KO) cells in comparison to their wild type (WT) counterparts 
(Mitsuishi et al., 2012). By estimating the ratio of ADP to oxygen as a measure of ATP synthesis it was 
found that NRF2 deficiency results in a decreased efficiency of oxidative phosphorylation, whereas 
activation of NRF2 has the opposite effect. Furthermore, Nrf2 deficiency leads to ATP production 
primarily through glycolysis, and this ATP is then used F1F0-ATPase to maintain the Δψm (Holmström et 
al., 2013).  
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Recent evidence has suggested that NRF2 links mitochondrial biogenesis to oxidative stress. The role of 
PGC-1α in ROS metabolism was previously explored (St-Pierre et al., 2006). The expression of 
mitochondrial ROS-detoxifying enzymes including superoxide dismutase 2 (SOD2) increased with PGC-
1α (St-Pierre et al., 2006). The PGC-1 family of coactivators plays a central role in a regulatory network 
governing the transcriptional activation of mitochondrial biogenesis and respiratory function. These 
coactivators target multiple transcription factors including nuclear respiratory factor 1 (NRF1) and the 
orphan nuclear hormone receptor, ERRα, among others to trigger expression of mitochondrial proteins 
(Wu et al., 1999, Schreiber et al., 2004, Scarpulla, 2011). Activation of NRF2 with sulforaphane 
increased mitochondrial mass and induction of PGC1α and PGC1β (Brose et al., 2012) as well as NRF1 
(Piantadosi et al., 2008). Taken together, these results suggest that the role of NRF2 in maintaining the 
levels of both NRF1 and PGC1α is complex and becomes prominent under conditions of oxidative stress.  
The role of NRF2 in removal of damaged/dysfunctional mitochondria represents another layer of the 
broad cytoprotective mechanisms orchestrated by this transcription factor through mediating expression 
of mitophagy and autophagy associated genes including PTEN-induced putative kinase 1 (PINK1) and 
p62 (Jain et al., 2010, Komatsu et al., 2010, Jiang et al., 2015, Murata et al., 2015). These observations 
suggest that the Keap1/NRF2 pathway regulates both mitochondrial homeostasis and ROS production.  
1.2.6.2.  Autophagy/mitophagy 
 
Autophagy is a catabolic process that is responsible for the bulk removal of cytoplasmic components 
including damaged organelles, miss-folded proteins and elimination of intracellular pathogens 
(Mizushima, 2007, Mizushima et al., 2008, Jiang et al., 2015). This degradation process is needed to 
preserve cellular homeostasis and defend against oxidative or proteotoxic stress. Signals of extracellular 
and intracellular origin can trigger autophagy, such signals include oxidative stress (Kiffin et al., 2006), 
endoplasmic reticulum stress (Yorimitsu et al., 2006), or nutrient deprivation (Yang and Klionsky, 2010). 
Mitophagy is the selective autophagic clearance of dysfunctional mitochondria and can be regarded as a 
targeted defence against oxidative stress (Lemasters, 2005, Zhang, 2013). 
In mammals, the autophagic removal of mitochondria is dependent on two genes. The PTEN-induced 
putative kinase 1, which codes for a kinase localised to the mitochondrial membrane, and PARK2, whose 
protein product, Parkin, is a cytosolic E3 ubiquitin ligase (Narendra et al., 2008, Geisler et al., 2010).  
Under basal conditions, the translocase of the outer membrane (TOM) and translocase of the inner 
membrane (TIM23) complexes allows for PINK1 to be imported into mitochondria in a process 
dependent on a mitochondrial targeting sequence (Lazarou et al., 2012, Pickles et al., 2018). Upon entry 
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and at the outer mitochondrial membrane, PINK1 is processed by the matrix peptidase (MPP) and the 
inner membrane protease PINK1/PGAM5- associated rhomboid-like protease (PARL) (Jin et al., 2010). 
The resulting cleaved product with an amino-terminal is released into the cytoplasm and degraded (Figure 
1.14A) (Yamano and Youle, 2013).  
Compromised mitochondrial protein import causes stabilisation of PINK1 on the outer mitochondrial 
membrane (OMM) (Narendra et al., 2008) in a complex composed of TOM20, TOM22, TOM40 and 
TOM70 (Lazarou et al., 2012, Okatsu et al., 2013). PINK1 kinase activity leads to Parkin translocation 
from the cytoplasm to the PINK1-bound organelle, and is therefore essential for Parkin recruitment 
(Vives-Bauza et al., 2010, Okatsu et al., 2012). In addition to auto-phosphorylation, PINK1 can 
phosphorylate Parkin on Serine 65 of its ubiquitin-like domain, thereby increasing its E3 ligase activity to 
recruit additional proteins necessary for removal of damaged mitochondria (Figure 1.14B) (Kane et al., 
2014).  
Proteins belonging to the family of autophagy related genes (ATGs) coordinate the expansion of the 
phagophore to form the autophagosome (Burman and Ktistakis, 2010). Autophagy receptor proteins bind 
ubiquitinated cargo through their ubiquitin-binding domains and connect them to the autophagosome to 
promote autophagy. Sequestosome 1 (SQSTM1) or p62 has been proposed to act as a receptor linking 
depolarised mitochondria to microtubule-associated protein 1A/1B-light chain 3 (LC3) on 
autophagosomes to (Ashrafi and Schwarz, 2013). Furthermore, p62 is required for the perinuclear 
clustering of depolarised mitochondria (Okatsu et al., 2010).  
Both autophagy and mitophagy can mitigate the potential cellular damage caused by dysfunctional 
mitochondria through down regulation of the NLRP3 inflammasome activation and apoptosis as well as 
preventing the generation of excess ROS by removing these damaged organelles (Kim et al., 2007, Zhou 


















Figure 1.14: PINK1 and Parkin co-operate to induce mitophagy. (A) Under basal conditions PINK1 
undergoes proteolytic cleavage by the matrix protein MPP and by the inner mitochondrial membrane 
protein PARL. Processed PINK1 is then targeted to the proteasome for degradation. (B) Upon damage, 
PINK1 import is compromised and is stabilised on the OMM, where it phosphorylates both Parkin and 
ubiquitin. Parkin is then recruited to phosphorylated ubiquitin to signal for autophagic clearance of the 
damaged organelles (Eiyama and Okamoto, 2015).  
1.2.6.3.  Sirtuins   
 
To protect cells from stress induced damage and maintain homeostasis, mitochondria upregulate 
responses that are referred to as mitochondrial stress responses, these include the UPR
mt
, antioxidant 
defences and mitophagy (Barbour and Turner, 2014). Sirtuins have received considerable attention as 
mediators of cytoprotective adaptations to mitochondrial stress as well as several roles in the regulation of 
metabolism and related diseases (Lin et al., 2018).   
Sirtuins are a family of highly conserved NAD
+
 dependent deacetylases (Saunders and Verdin, 2007). All 
SIRTs contain a highly conserved catalytic core which has a structurally homologous and large 
NAD
+
/NADH binding Rossmann-fold domain, zinc-binding domain and numerous loops that form a 
cleft. This cleft attaches the two domains where the NAD
+
 and acetyl lysine containing protein substrates 
enter and bind to the enzyme for deacetylation. The mammalian SIRT homologs (SIRT1-7) display a 
wide range of tissue specificity, subcellular localization; enzymatic activity and protein targets (table 
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1).The mitochondrial specific SIRTs (SIRT 3, 4 and 5) can directly influence mitochondrial activity and 
stress responses (Lin et al., 2018).  
Table 1: Localization and function of the mammalian SIRT homologs 
 
1.2.6.3.1. Mitochondrial SIRTs and oxidative stress 
 
Sirtuins are regarded as energy sensors due to their dependence on NAD
+
 (Li and Kazgan, 2011). The 
three mitochondrial sirtuins: SIRT3, SIRT4, and SIRT5 are mainly found in the matrix due to the 
presence of a mitochondrion targeting sequence in their N terminals (Haigis and Guarente, 2006). Sirtuins 
participate in antioxidant defence to combat mitochondrial stress. The SOD2 antioxidant enzyme is the 
primary scavenger of superoxide in the mitochondria (Kokoszka et al., 2001, Indo et al., 2015). Sirtuin 3 
is indispensable for cellular antioxidant defence by activating SOD2 activity via deacetylation of lysine 
68 (Chen et al., 2011) and by indirectly enhancing SOD2 expression via the deacetylation of FOXO3A 
(Zhang et al., 2014). This deacetylase also increases the transcriptional activation of PGC-1α to suppress 
oxidative stress and increase mitochondrial biogenesis (Kong et al., 2010).  
























SIRT7 Nucleolus Deacetylase 
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Sirtuin 4 demonstrates a negative role in mitochondrial function and promotes ROS production. 
Mitochondrial depolarization is promoted by elevated expression of SIRT4 as well as loss of 
mitochondrial function and reduced mitochondrial oxygen consumption. It was recently shown that 
SIRT4 disrupts PDH activity, thus inhibiting ATP production (Mathias et al., 2014).  
Sirtuin 5 elicits antioxidant potential via two mechanisms. First, SIRT5 protects cells from apoptosis and 
this involves the forkhead box O3 (FOXO3A) induced clearance of ROS by SOD2 in cells treated with 
cigarette smoke extract (Wang et al., 2015b). Second, SIRT5 promotes the desuccinylation and 
deglutarylation of isocitrate dehydrogenase 2 (IDH2) and glucose-6-phosphate dehydrogenase (G6PD) 
respectively, increasing their catalytic activities, maintaining NADPH homeostasis and redox potential 
and contributing to oxidative stress resistance (Zhou et al., 2016).  
1.2.6.3.2. Mitochondrial SIRTs and Mitophagy 
 
Mitophagy is critical for maintaining mitochondrial homeostasis in response to stress. Sirtuin 3 facilitates 
mitophagy by deacetylating FOXO3A which is indispensable for inducing mitophagy  (Tseng et al., 
2013). Moreover, SIRT3 is required for enhancing the lipidation and transcript levels of LC3B which 
promotes mitophagy (Liang et al., 2013). Sirtuin 4 was observed to downregulate mitophagy. The 
translocation of Parkin to the mitochondria was decreased in SIRT4-overexpressing cells, indicating that 
Parkin-associated mitophagy was reduced when SIRT4 was overexpressed (Lang et al., 2017). An 
increasing number of studies support the regulatory role of SIRT5 in mitophagy. Polletta et al. (2015) 
showed that mitophagy markers ( Pink1 and Parkin) increased when SIRT5 was silenced or 
pharmacologically inhibited, while these same markers decreased in cells overexpressing SIRT5 (Polletta 
et al., 2015). These results indicate that SIRT5 is involved in repressing mitophagy. SIRT5 may also 
increase resistance to mitophagy by inhibiting mitochondrial fission. The mitochondrial degradation 
increased after SIRT5 knockout and was blocked after autophagy inhibitor treatment, indicating the 
repressive role of SIRT5 in mitophagy (Guedouari et al., 2017). The repressed mitophagy may be 
attributed to SIRT5-induced inhibition of mitochondrial fission. Taken together, SIRT5 may have both 
direct and indirect impacts on mitophagy. 
1.2.6.3.3. Mitochondrial SIRT3 and SIRT5 regulation 
 
The transcriptional co-activator PGC-1α is essential for maintaining mitochondrial function and 
protection through up-regulation of SOD2 (Leick et al., 2010, Lu et al., 2010). PGC-1α is considered the 
master regulator of mitochondrial biogenesis and respiration (Ventura-Clapier et al., 2008, Fernandez-
 35 
 
Marcos and Auwerx, 2011). The elucidation of the transcriptional regulation of diverse metabolic 
pathways have led to the discovery of mitochondrial SIRTs (3 and 5) as putative downstream targets of 
PGC-1α (Kong et al., 2010, Buler et al., 2014). 
The mitochondrial SIRTs are also regulated at the epigenetic level by microRNAs (miRNAs) (Zhang et 
al., 2018). These are small, non-coding RNA molecules which act as post-transcriptional regulators of 
gene expression. Individual miRNAs can regulate the expression of multiple genes and individual genes 
can be regulated by several miRNAs (He and Hannon, 2004). MicroRNAs regulate gene expression by 
acting as RNA silencers or posttranscriptional gene regulators (Figure 1.15). During the first step of 
protein synthesis, the DNA which codes for the protein of interest is synthesised into mRNA 
(transcription). In the absence of miRNA, the mRNA is converted into protein (translation). In the 
presence of miRNA with near-perfect, partial complementarity to the mRNA of interest, miRNA binds in 
the three prime untranslated region (3′ UTR) and represses translation, thus inhibiting protein synthesis. 
In the presence of miRNA with perfect complementarity, miRNA binding in the 3′ UTR is thought to 
degrade mRNA and inhibit protein synthesis. In humans, perfect complementarity is rare, with varying 












Figure 1.15: Representation of MiRNA mechanism of action (Romaine et al., 2015) 
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Mycotoxins exert a plethora of effects in organisms that may lead to adverse health effects. Although 
common contaminants of food sources, they receive minimal attention, particularly in terms of 
mechanistic data. There is a need to better understand the toxicological profile of these foodborne toxins, 
thus improving regulations and laws to protect consumers. This study examined the effects of a neglected 
fusrariotoxin and its implications for humans through the use of an in vitro metabolic model. 
Fusaric acid is regarded as a putative mitochondrial toxin; however, there remains a dearth of knowledge 
regarding the molecular events that contribute to mitochondrial dysfunction and its links to aberrant 
metabolism and inflammatory responses. This study aimed to integrate the mechanisms of mitochondrial 
dysfunction and downstream implications to provide relevant insight into the toxic potential of this 
neglected mycotoxin. 
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Fusaric acid induces mitochondrial stress in human hepatocellular carcinoma (HepG2) cells.  
 
Fusaric acid is a ubiquitous but neglected mycotoxin and is considered toxicologically significant only 
when in the presence of co-produced mycotoxins such as FB1. Fusaric acid is described as a putative 
mitochondrial toxin, however exact mechanisms remain elusive. This paper established mechanisms of 
mitochondrial toxicity induced by FA in HepG2 liver cells and its implications on cell viability, 
mitochondrial biogenesis and cell death.  
 
This manuscript was published in the Elsevier journal of Toxicon (2016), 119:336-344, and is included in 









































Fusaric acid upregulates NRF2 as a Cytoprotective Response to Prevent NLRP3 activation in 
HepG2 liver derived cells 
 
In chapter 2 the mitotoxic potential of FA in a human derived liver cell model was established. This 
chapter further explored the implications of FA induced mitochondrial and oxidative stress on the 
inflammatory pathways with particular focus on IL-1β processing. Fusaric acid repressed NLRP3 priming 
and activation through mitophagic clearance of damaged mitochondria. This paper highlights FA as an 
immune suppressor despite mitochondrial toxicity.   
This manuscript has been submitted to Toxicology in vitro (Manuscript reference: TIV_2018_344). At the 
time of thesis submission this manuscript was invited for re-submission with minor revisions. The 
amended manuscript has been included below and formatted as per journal requirements (Revision 1, 
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The neglected foodborne mycotoxin Fusaric acid induces bioenergetic adaptations by 
switching energy metabolism from mitochondrial processes to glycolysis in a human liver 
(HepG2) cell line 
 
Mitochondrial toxicity and dysfunction is often associated with aberrant energy metabolism and can 
result in metabolic switching. This metabolic switch and subsequent metabolic inflexibility is a 
characteristic of the Warburg effect and cancer cells. In this chapter liver cells were supplemented 
with different carbon energy substrates to determine the effects of FA on mitochondrial ATP 
output. A shorter time period (6 hours) was selected for this study to determine mitochondrial 
toxicity in the absence of overt cytotoxicity. Galactose and palmitate were used as alternate fuel 
carbons to stimulate OxPhos and β–oxidation respectively. Fusaric acid rendered glucose as the 
preferred energy substrate and induced a phenotype reminiscent of the Warburg effect in HepG2 
cells through constitutive up-regulation of HIF-1α and subsequent inhibition of PDH.  
This manuscript was submitted to Scientific Reports (Manuscript reference: SREP-18-28513). At 
the time of submission this manuscript has been invited for re-submission to address minor 
revisions. The amended article has been included below and formatted as per journal requirements 
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Metabolic flexibility defines the capacity of cells to respond to changes in nutrient status. 
Mitochondria are important mediators of metabolic flexibility and dysfunction is associated with 
metabolic inflexibility and pathology. Foodborne toxins are often overlooked as potential factors 
contributing to metabolic toxicity. Fusaric acid (FA), a neglected mycotoxin, is known to disrupt 
mitochondrial function. The aim of this study was to investigate the molecular mechanisms 
underlying a metabolic switch in response to FA. This study investigated the effects of FA on 
energy homeostasis in cultured human liver (HepG2) cells. HepG2 cells poised to undergo 
oxidative and glycolytic metabolism were exposed to a range of FA concentrations (4, 63 and 250 
µg/mL) for 6 hours. We determined mitochondrial toxicity, acetyl-CoA levels and cell viability 
using luminometric, fluorometric and spectrophotometric methods. Expression of metabolic 
proteins (PDK1, PKM2, phosphorylated-PDH E1α and HIF-1α) and mRNAs (HIF-1α, PKM2, 
LDHa and PDK1) were determined using western blot and qPCR respectively. Our data connects a 
constitutive expression of HIF-1α in response to FA to the inhibition of pyruvate decarboxylation 
through up-regulation of PDK-1 and phosphorylation of Pyruvate Dehydrogenase E1α subunit. 
Moreover, we highlight the potential of FA to induce a glucose “addiction” and phenotype 
reminiscent of the Warburg effect. The findings provide novel insights into the impact of this 
neglected foodborne mycotoxin in the dysregulation of energy metabolism.  
Keywords:   Metabolic inflexibility 
Mitochondria 
Pyruvate dehydrogenase complex 








1. Introduction  
The contamination of plants with mycotoxins is a growing problem throughout the world. 
Mycotoxins are a heterogeneous group of compounds that exert toxic effects in vertebrates. Of 
particular concern are the Fusarium toxins which are considered the most frequently occurring 
foodborne mycotoxins worldwide 
1-3
. Fusaric acid (5-butylpicolinic acid, FA) is an often 
“neglected” polyketide derived secondary metabolite 4.  This mycotoxin is of interest because of its 
ubiquitous production by several fusarium species that commonly contaminate agriculturally 
important crops such as corn 
5
, with amounts as high as 643 µg/kg of sample being documented 
6
. 
FA is a natural chelator of divalent cations 
7,8
 in addition to its associated plant pathogenicity 
9,10
 
and reported “mild” toxicity in animals 11,12. FA shows strong synergism with co-produced 
fusariotoxins 
13-15
, while FA alone results in teratogenicity 
8,16
 and overall cytotoxicity in recent 
studies on human derived cell lines 
17-19
. Although exact mechanisms of FA toxicity are yet to be 
elucidated, human in vitro models have highlighted genomic, oxidative and mitochondrial toxicity 
17,19,20
. Despite the established mitochondrial toxicity of FA in vertebrates 
17,21
 little is known about 
its effects on cellular energy metabolism. 
Mitochondria regulate important energy processes in response to nutrient availability, thus making 
them key role players in metabolic flexibility (capacity to switch between energy substrates) 
22
. 
Most cells exhibit a degree of metabolic flexibility to meet bioenergetic demands and cope with 
changes to the cellular environment 
23
. The pathologic potential of such shifts is exemplified by the 
switch from mitochondrial oxidative phosphorylation (OxPhos) to aerobic glycolysis (Warburg 
effect) which is strongly associated with a cancer cell phenotype and aberrant proliferation 
24,25
.  
The metabolic program is an active modulator of cellular phenotype 
26
 and changes to the metabolic 
program can influence multiple signalling cascades by providing or limiting substrates for cell 
protection or death 
27
. Hypoxia inducible factor-1 (HIF-1) has been implicated as a key regulator of 
cancer cell glucose metabolism by upregulating expression of glycolytic enzymes and their activity. 
These enzymes result in the shunting of pyruvate away from the tricarboxylic acid cycle (TCA) and 
towards glycolysis via inhibition of the mitochondrial pyruvate dehydrogenase complex (PDC), 
leading to accumulation of lactate 
28,29
. This multi-enzyme complex links glucose metabolism, fatty 
acid metabolism and the TCA cycle by acting as the branching point between substrate production 
and utilisation to maintain metabolic homeostasis. Dietary bioactive compounds are known to have 
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profound therapeutic effects by mitigating metabolic inflexibility 
30
, however very little is known 
regarding common foodborne toxins and their roles in metabolic disease initiation and progression. 
Evidence suggests that mammalian cells redirect their energy metabolism in response to available 
carbon sources in culture media 
31
. Cells cultured in galactose as the main fuel source are forced to 
rely on mitochondrial OxPhos to generate ATP since no net ATP is generated from galactose 
metabolism. Hence evaluation of mitochondrial dysfunction using comparative effects between 
glucose and galactose can demonstrate sensitization to mitochondrial toxins such as FA 
32
. 
Consistent with this methodology we sought to determine the underlying molecular mechanisms of 
FA on energy metabolism in the liver derived HepG2 cell line.  
2. Results  
 
2.1. FA impairs mitochondrial function without overt necrosis 
A compound is considered a potential mitochondrial toxin if it decreases the ATP measure by 
greater than 20% of the average of control cells with less than a 20% increase in cytotoxicity. To 
assess loss of mitochondrial function in response to FA, HepG2 cells were cultured under glycolytic 
and aglycolytic conditions. Immortalised cells grown in glucose rich media derive their ATP from 
glycolysis and by-pass OxPhos. By substituting glucose with galactose, cells are forced to use 
OxPhos to meet their ATP demands. These cells are aerobically poised and more susceptible to 
mitochondrial toxins. This is reflected in the severe decrease of ATP levels in the GAL 
supplemented media (Fig 1C), when compared to ATP levels in glucose supplemented cells which 
remained above 50% (Fig 1A and 1B) post FA exposure. To validate mitochondrial toxicity as a 
measure of intracellular ATP, HepG2 cells were incubated under the same metabolic conditions in 
the presence of the F0-F1 ATP synthase inhibitor, oligomycin A. Treatment with oligomycin A 
affirmed the mitotoxic potential of FA by having a more drastic effect on GAL using cells as 
compared to glucose supplemented cells (Fig 1A-1C). We further show that a relationship exists 
between the dose of FA and mitochondrial toxicity (ATP output via OxPhos). The mitotoxic dose of 
FA is much lower in aerobically poised cells (Fig 1C) than in cells primarily deriving ATP from 
glycolysis (Fig 1A and 1B).  
 
The simultaneous assessment of intracellular ATP levels and cell membrane integrity (marker for 
cellular toxicity) is a good indicator of early mitochondrial dysfunction before overt necrosis. 
Cellular cytotoxicity was not observed under any of the tested culture conditions regardless of the 
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FA dose (Fig 1A-1C). Taken together these data reveal that FA induces considerable mitochondrial 
dysfunction without overt necrosis in all tested energy substrate models (Fig. 1A-1C).    
 
 
Fig. 1 The effect of FA on ATP levels and cytotoxicity in HepG2 cells. Serial concentrations of FA 
(µg/mL) and oligomycin A (μM) were tested in GLUC (A), HG (B) and GAL (C) supplemented 
media. FA inhibited ATP production in a dose dependent manner without causing overt 
cytotoxicity. The reduction in ATP with no loss to membrane integrity indicates that the compound 
is a mitochondrial toxin. The values are expressed as a percentage of the control ± SD (n=3).  
 
2.2. FA influences cytoplasmic NAD(P)H 
The WST-1 assay was used to quantify cytoplasmic NADPH generated under the selected substrate 
conditions. NADP
+
 is a required co-factor for glucose-6-phosphate generation via glucose-
6phosphate dehydrogenase (an early event of glycolysis) 
33,34
.  Cells cultured in glycaemic media 
(GLUC and HG) were stimulated to undergo glycolysis (as indicated by absorbance readings above 
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those seen in respective controls) regardless of FA dose. In contrast cells poised to undergo OxPhos 
showed increased NADPH levels only at mid to high FA concentrations (63 µg/mL - 250 µg/mL). 
These observed effects are considered biphasic with a low dose stimulatory effect and a high dose 
inhibitory effect (Fig 2A) that may be dependent on FA toxicodynamics (recovery equals injury) 
and toxicokinetics (elimination equals absorption). To validate this hypothesis and rule out 
mitochondrial reducing equivalent metabolism under tested substrate conditions, Rotenone, a 
mitochondrial complex 1 inhibitor was used. NADPH in glucose supplemented cells incubated with 
rotenone for 6 hrs was elevated when compared to OxPhos (GAL) stimulated cells (Fig 2B). This 
suggests enhanced glycolytic rates in response to mitochondrial toxins and maintenance of ATP 
levels. This provides evidence that FA shifts metabolism to a more glycolytic endpoint. 
Furthermore, the response to rotenone plateaus after the initial inhibitory concentration further 























Fig. 2 Cytoplasmic levels of NADPH in HepG2 cells supplemented with GLUC, GAL and HG after 
treatment with varying FA concentrations. FA induces a biphasic response in which NADPH 
generation is characterised by low dose stimulation and high dose toxic effect. (A). Rotenone 
drastically depleted NADPH levels in cells treated with GAL (B). Values are expressed as mean 




2.3. FA facilitates metabolic flux away from the TCA cycle 
In glycolysis glucose is metabolised to pyruvate in the cytoplasm. Pyruvate can be metabolised 
either to lactate (augmenting glycolysis), or acetyl-CoA in the mitochondrion by PDH to serve as a 
substrate for the TCA cycle. Having established that FA is a mitotoxin, we investigated the fate of 
pyruvate by quantifying acetyl-CoA and lactate concentrations. FA treated cells showed a 
significant, dose dependent decrease in acetyl-CoA upon supplementation with GLUC and GAL 
(Fig 3A and 3C, p <0.0001) when compared to control. However, acetyl-CoA in HG supplemented 
cells showed minimal changes (Fig 3B). It is noteworthy that the PDH activator, DCA significantly 
elevated acetyl-CoA levels in all tested models (Fig 3A-3C). Analysis of lactate levels revealed FA 
to induce an increase in glycolytically poised HepG2 liver cells (GLUC p = 0.0042 and HG p = 
0.0009, Fig 3D and E). Moreover, stimulation of OxPhos did not prevent FA from elevating lactate 
production (p < 0.0001, Fig 3F).  
 
We then determined whether the changes to acetyl-CoA and lactate levels were the result of a 
corresponding inhibition of PDH. Phosphorylation of PDH E1α (S293) is important for down 
regulation of enzyme activity. FA significantly increased phosphorylation of the PDH E1α subunit 
in a dose dependent manner compared to untreated cells (GLUC p < 0.0001, HG p < 0.0001,  GAL 
p < 0.0001) while PDH phosphorylation was reduced in DCA treated cells in GLUC and GAL, thus 
strongly indicative of a glycolytic switch. In contrast, DCA induced a high degree of PDH 




Fig. 3 FA attenuates pyruvate decarboxylation. A dose dependent decrease in acetyl-CoA levels 
was observed in FA treated cells (A-C) along with elevated lactate levels (D-F). Western blot 
detection of serine 293 phosphorylation showed FA increased expression of inactive PDH E1α (G-
I). The results are expressed relative to the control ± SD (n=3).    
Key 
vs control ***p< 0.001, **p<0.01, *p<0.05 















2.4. FA mediated induction of HIF-1α 
Given the role of HIF-1α in glucose metabolism and glycolytic switch we investigated the 
expression of this transcription factor at both mRNA and protein levels. A basal level of HIF-1α 
under normoxic conditions was observed in untreated cells and served as a control to which FA 
stimulated cells could be compared. qPCR analysis revealed mRNA levels of HIF-1α to be dose 
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dependently increased in response to FA. However, only at a concentration of 250 µg/mL was 
statistical significance observed across all tested energy substrates (p < 0.0001, Fig. 4A-4C).  
Western blot analysis was performed to investigate the stability of HIF-1α in response to FA under 
normoxic conditions. In GLUC supplemented cells FA elevated the expression of HIF-1α at low 
concentrations but this was reversed at 250µg/mL of FA (p < 0.0001, Fig. 4D). Moreover, 
supplementation with GAL and HG effectively increased the expression of HIF-1α in a dose 
dependent manner (p < 0.0001, Fig. 4E and 4F). Taken together these data indicate FA promotes 



















Fig. 4 Effects of FA on HIF-1α expression and stability under normoxia post FA exposure. HIF-1α 
mRNA (expression) was assessed with qPCR (A-C). HIF1-α protein expression (stability) was 
assessed by western blot (D-F). FA induces HIF-1α accumulation under the tested substrate 
conditions. The results are expressed relative to the control ± SD (n=3).    
Key 
vs control ***p< 0.001, **p<0.01, *p<0.05 

















2.5. FA dampens kinase expression  
The phosphorylation and activity of PDC is regulated by PDH kinase 1 (PDK1). To examine the 
effects of FA on PDC regulation qPCR and western blot was performed to determine the expression 
profiles of PDK1. At the transcript level FA increased PDK1at the two highest concentrations in 
GLUC model (p = 0.0003, Fig 5A). In HG, FA showed a significant increase only at 63µg/mL, 
while a highly significant decrease was observed at 250µg/mL relative to the control (< 0.0001, Fig 
5B). In cells forced into OxPhos metabolism (GAL supplementation), PDK1 expression increased 
significantly at a FA concentration of 63 µg/mL (p < 0.0001, Fig 5C). 
Under GLUC conditions FA increased the expression of PDK1 in a dose dependent manner, while 
HG supplemented cells showed steep increases at lower FA concentrations but a significant 
decrease at 250µg/mL (p < 0.0001, Fig 5D and 5E). In contrast, cells forced to undergo OxPhos 
(GAL supplemented cells) showed increased PDK1 expression only at 63 µg/mL when compared to 
control (< 0.0001, Fig 5F).  
 
 Fig. 5 Effects of FA on PDK1 protein and gene expression. FA induced a sharp increase to both 
mRNA (A-C) and protein levels (D-F) at 63µg/mL. In contrast strong decreases to mRNA (A-C) 
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and protein expression (D-F) were observed at highest FA concentration across all selected 
metabolic substrates. The results are expressed relative to the control ± SD (n=3).    
Key 
vs control ***p< 0.001, **p<0.01, *p<0.05 















2.6. FA shunts metabolism toward glycolytic endpoints  
Given the established role of HIF-1α in circumventing pyruvate decarboxylation and OxPhos we 
examined targets of this transcription factor related to glycolysis induced by FA. Pyruvate kinase 
isoform M2 (PKM2) catalyses the final step of glycolysis. FA significantly increased gene 
expression of PKM2 in all experiments relative to the control (GLUC p = 0.0002, HG p = 0.0012, 
GAL p < 0.0001, Fig. 6A-C). We further evaluated the effects of FA on PKM2 protein expression. 
In GLUC cultured cells there was increased PKM2 expression at all FA concentrations relative to 
the control (p < 0.0001, Fig. 6D). Cells cultured in HG showed a dose dependent decrease in PKM2 
after FA stimulation; however protein expression was still higher in treated cells when compared to 
control (p < 0.0001, Fig. 6E). We also observed cells cultured in aglycaemic conditions (GAL) 
showed a dose dependent increase to PKM2 protein levels relative to the control (p < 0.0001, Fig. 
6F). In contrast the PDH stimulator DCA decreased the expression of PKM2 across all culture 
conditions (Fig. 6D-F).  
Since the intracellular fate of glucose seemed to be off set by FA we investigated the gene 
expression of LDHa, the enzyme catalysing the conversion of cytosolic pyruvate to lactate. We 
observed a peak in expression at 63µg/mL with strong represssion at the highest FA concentration 
in all culture conditions (Fig. 6G-I). These data point to a cytosolic fate for pyruvate and energy 




Fig. 6 FA enhances cytosolic energy metabolism. The effects of FA on mRNA expression (A-C) 
and protein expression (D-F) for PKM2 was assessed. Transcript levels of the cytosolic enzyme 
LDHa was also determined (G-I). The results are expressed relative to the control ± SD (n=3).  
Key 
vs control ***p< 0.001, **p<0.01, *p<0.05 















2.7 FA renders glucose as preferred metabolic substrate  
After confirming that FA upregulated glycolytic enzyme expression, we then investigated if cells 
could generate ATP through β-oxidation. For this we assessed ATP and biomass as measures of cell 
viability upon addition of glucose free-FFA. There was a significant dose dependent decrease in 
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ATP levels in palmitate supplemented cells when compared to glycaemic cultures (p < 0.0001, Fig 
7A). Furthermore, treatment with FA under FFA and GAL conditions led to a significant and major 
decrease in biomass further highlighting preferential glucose utilisation in FA treated cells (GAL p< 




























Fig. 7 Glucose dependence in the presence of FA: FA depleted ATP at higher concentrations across 
all energy substrates (A). Cell biomass was minimally affected under glycaemic conditions (GLUC 
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and HG) but severely reduced in aglycaemic media (GAL and FFA, B). The results are expressed 
relative to the control ± SD (n=6). 
Key 
vs control ***p< 0.001, **p<0.01, *p<0.05 
















We report on the impact of the Fusarium mycotoxin FA on mitochondrial toxicity and its outcome 
on cell energy metabolism in human liver (HepG2) cells. Determining mitochondrial toxicity in 
vivo is a challenge given that typical rodent models possess large respiratory capacity and that these 
efficiently functioning mitochondria can tolerate toxic insults 
35
. Culturing of HepG2 cells in media 
substituted with GAL leads to circumvention of the Crabtree effect and stimulates OxPhos 
32
; this 
model is considered relevant in determining mitochondrial toxicity and subsequent metabolic 
implications 
32,35,36
. Using this model we investigated FA mediated glycolysis and glucose shunt at 
the molecular level in HepG2 cells. We show, for the first time, that FA impedes pyruvate 
decarboxylation while elevating expression of glycolytic enzymes and renders cells reliant on 
glucose to meet energy demands.  
 
Recent in vitro studies showed that FA decreased intracellular ATP levels and initiated cell death 
after 24h 
17-19
. By sequentially assessing cell membrane integrity and ATP content in OxPhos 
primed and glycolytic HepG2 cells after FA stimulation (6h), we demonstrate mitochondrial 
dysfunction in the absence of overt cytotoxicity (Fig 1). Substantial decrease in ATP concentration 
was observed in GAL supplemented cells when compared to glycolytic cells where ATP synthesis 
was maintained by glycolysis (Warburg effect). This is affirmed by the inclusion of the classic 
mitochondrial toxin oligomycin A. These findings are in accord with studies that highlight the 
primarily mitochondrial effect of FA 
17,21
. Telles-Pupulin (1998) found that FA repressed 
mitochondrial metabolism by inhibiting key enzymes involved in the TCA cycle and OxPhos 
21
. A 
recent study by our group showed FA to down regulate the expression of the mitochondrial 
deacetylase sirtuin 3, and inhibit mitochondrial biogenesis 
17
.  Thus FA can directly and indirectly 





Consequently, we hypothesised that the maintenance of ATP in glucose supplemented cells relative 
to OxPhos primed cells represents a compensatory shift toward glycolysis. WST-1 assayed 
cytosolic NADPH as an indirect measurement of glucose-6-phosphate dehydrogenase activity and 
marker of early glycolytic switch 
33,34
. The glucose free GAL model revealed drastic suppression of 
NADPH synthesis suggesting enhanced glycolytic processing in glucose supplemented cells (Fig 2). 
The combined down regulation of mitochondrial ATP synthesis and up-regulation of cytoplasmic 
ATP synthesis further highlight the mitotoxic potential of FA.     
 
We then investigated the intracellular fate of glucose offset by FA. Pyruvate is the end product of 
glycolysis and is at the branch point of cellular glucose metabolism. Cytosolic processing of 
glucose results in lactate production while PDH routes pyruvate to acetyl-CoA synthesis for use as a 
TCA cycle substrate 
37
. Our results show that FA reduced acetyl-CoA levels in GLUC and GAL 
supplemented cells but not in those cultured under HG conditions (Fig. 3A-C). FA was shown to 
undergo chain elongation to form fusaryl CoA derivatives using acetyl-CoA as a C2 donor 
38
 leading 
us to speculate that this mycotoxin can directly deplete acetyl-CoA pools. Further investigation into 
the effects of FA on acetyl-CoA synthesis revealed enhanced phosphorylation of PDH-E1α 
(Ser293) demonstrating inactivation of this important mitochondrial enzyme (Fig. 3 F-I) 
39,40
. In 
support of our observations, the pharmacological activation of PDH by DCA showed elevated 
acetyl-CoA levels across all tested energy substrates 
41
. Moreover, elevated lactate levels (Fig 3D-F) 
highlight the shunt of glucose toward cytosolic energy generation in FA stimulated cells. From 
these data it seems that FA facilitates glucose flux away from the TCA cycle and toward glycolysis.  
 
Increased PDH phosphorylation under hyperglycaemic is mediated by enhanced mitochondrial 
deacetylation 
42
. Furthermore, DCA was shown to increase both acetyl-CoA levels and protein 
acetylation in a mouse model 
41
. These results are in line with our hypothesis that FA induces 
metabolic inflexibility since FA has previously been shown to downregulate sirtuin 3 (primary 




The post translational modification of PDH was investigated by examining the expression profile of 
the serine kinase PDK1 by FA in cells. PDK1 dependent inhibition of PDH prevents pyruvate 
decarboxylation to acetyl-CoA, this results in reduced flow of glucose derived pyruvate into the 
TCA cycle 
43
. FA elevated the transcription and translation of PDK1 in glycolytic and aglycolytic 
cells (Fig 5). PDK1 is considered as the most potent inactivator of PDH. PDK1 phosphorylates 
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PDH at three primary sites where it brings about strong phosphorylation and poor 
dephosphosphorylation of PDH blocking substrate (pyruvate) binding 
39,44
. Furthermore, it has 
recently been established that PDK1 is specifically required for adaptation to metabolic stressors 
43
. 
Based on these findings it seems FA facilitates glucose flux away from the TCA cycle and OxPhos.  
 
Accumulating evidence shows that transcriptional activation and stabilisation of HIF-1α plays a 
crucial role in glycolytic metabolism and metabolic reprograming 
45
. Hydroxylation of HIF-1α by 
iron dependent prolyl hydroxylases (PHDs) under normoxia allows the von Hippel-Lindau protein 
(VHL) to ubiquitinate HIF-1α for proteasomal degradation. During hypoxia, HIF-1α is saved from 
degradation allowing for accumulation and import into the nucleus 
46,47
; FA induced HIF-1α 
transcription and stabilisation under normoxic conditions (Fig 4). However, transcription of HIF-1α 
lags behind its accumulating protein expression. These results suggest an important role for FA as a 
post-translational regulator given that such modifications reserved for proteins involved in rapid 
responses for cell adaptation to stress. In addition to oxygen dependent accumulation, loss of PHD 
and VHL function have been shown to induce HIF-1α stability. Iron chelators inhibit PHD and 
VHL by depleting Fe
2+
 allowing constitutive accumulation of HIF-1α, mimicking hypoxia 46,48. The 
chelation of iron by FA is well established in vitro 
7,49
. The nitrogen atom in the pyridine ring and 
the oxygen atom in the carboxyl group, may act as a chelator and form FA-iron complexes 
49
. The 
mechanism by which FA exerts its effects in vitro is similar to that of established iron chelators 




To validate this we examined targets of the HIF-1α transcription factor. HIF-1α promotes 
transcription of several glycolytic enzymes including PDK1, PKM2 and LDHa 
43,50,51
. FA elevated 
the expression of PDK1 mRNA most likely through HIF-1α activated transcription. Aberrant 
expression of PDK1 is often associated with disease progression due to its pivotal role in regulating 
metabolic flexibility by altering glucose flux away from pyruvate decarboxylation and OxPhos 
52
. 
Our study alludes to a signalling mechanism in which HIF-1α is the metabolic regulatory system in 
FA stimulated cells, resulting in a cell phenotype reminiscent of the Warburg effect.   
 
The Warburg effect is defined as a metabolic switch favouring pro-oncogenic glycolytic processes 
over OxPhos even in the presence of ample oxygen 
24,37,45
. Pyruvate kinase catalyses the final and 
rate limiting step of aerobic glycolysis in which phosphoenol pyruvate is converted to pyruvate 
producing ATP. The PKM gene is alternatively spliced to produce PKM1 and PKM2. The PKM2 
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variant is highly expressed in multiple cancer types including human hepatocellular carcinoma 
(HCC) 
53,54
. Previous studies have demonstrated that PKM2 gene transcription is regulated by HIF-
1α and that PKM2 directly interacts with HIF-1α to promote transcriptional activation of genes 
possessing the hypoxia response element suggesting that PKM2 and HIF-1α form part of a positive 
feedback loop 
55,56
. We demonstrated FA to be efficient at inducing the HIF-1α pathway activation 
and identified PKM2 expression for further study. Enhanced PKM2 expression was observed in 
response to FA. Interestingly pharmacological stimulation of PDH by DCA caused a significant 
decrease in PKM2 expression. Studies suggested that acetyl-CoA may be a regulator of PKM2 
37,57
. 
It therefore seems that FA promotes metabolic flux away from pyruvate decarboxylation.  
 
The cytosolic conversion of pyruvate to lactate by lactate dehydrogenase and its expression is often 
associated with the Warburg effect and tumorigenesis 
58
. We show that FA up-regulates 
transcription of LDHa across all tested energy substrates particularly at 63µg/mL (Fig. 6 G-I). 
Furthermore, OxPhos priming of HepG2 cells did not limit lactate production. (Fig 3F). Our data 
suggests that FA enhances the production of pyruvate and shunts this metabolite to lactate.  This 
further supports FA mediated stabilisation of HIF-1α since pyruvate and lactate are known to 
elevate HIF-1α expression 59.  
 
In most mammalian cells, oxidative metabolism by mitochondria generates substantial amounts of 
ATP needed for cell survival. Agents causing mitochondrial dysfunction often lead to loss of cell 
viability 
32
. Telles-Pupulin et al (1998) postulated that FA inhibited cellular processes related to 
mitochondrial energy metabolism and ATP generation 
21
. Free fatty acids such as palmitate offer an 
alternate source of ATP through β-oxidation in the mitochondria. The metabolic switch to 
glycolysis is highlighted by the major decrease in ATP levels in cells cultured in glucose free-FFA 
media (Fig. 7B). In support of this data, we observed strong decreases to cell biomass in aglycaemic 
media when compared to glucose supplemented cells (Fig. 7A). These data underline glucose as the 
preferred metabolic substrate in cells treated with FA.  
 
The findings of this study highlight a transition between adaptation and toxicity in response to FA at 
tested concentrations, particularly when molecular aspects of this work are scrutinised. In vitro 
studies offer the advantage of being highly homogenous, comprised of a population of cells with 
similar susceptibility to a particular toxin. Under these conditions it is reasonable to assume that the 
response of the liver derived HepG2 cell line to FA is a hormetic (biphasic) response characterised 
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by low dose stimulation and high dose inhibition 
60
 to several of the tested metabolic enzymes 
regardless of energy substrate. The exact mechanisms of hormesis induced by FA are unknown. 
Existing studies on FA used a variety of cell lines, doses and incubation periods 
17-21
, highlighting 
the need for more systematic experiments to elucidate the extent of such a biphasic dose response. 
Moreover, in view of the established mitochondrial toxicity of FA 
17,21
 it is necessary to also 
investigate whether stress responses mediate hormetic adaptation.   
 
Conclusion 
Given the current worldwide epidemic related to metabolic diseases it is becoming increasingly 
essential to understand how foodborne toxins such as FA might affect energy metabolism and 
flexibility. We demonstrate that FA oxygen-independently promotes HIF-1α expression and 
stabilisation which is associated with the metabolic shift away from pyruvate decarboxylation and 
toward a glycolytic phenotype reminiscent of the Warburg effect. Our findings add a novel aspect to 
the importance of neglected mycotoxin research particularly in the fields of metabolism and 










Fig. 8: Schematic diagram of the metabolic switch induced by FA. FA constitutively increases the 
expression of HIF-1α with subsequent transcriptional activation of PDK-1 that results in the 
inhibition of pyruvate decarboxylation. Furthermore, FA shunts pyruvate toward lactate production 
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by enhancing PKM2 and LDHa expression (A). Taken together, FA switches metabolism from 
OxPhos to glycolytic endpoint and induces a cell phenotype reminiscent of the Warburg effect (B). 
3. Methods and materials  
3.1. Reagents   
The HepG2 human liver derived cell line was acquired from Highveld Biologicals (Johannesburg, 
SA). Western blot reagents were purchased from Bio-Rad (Hercules, CA, USA). FA isolated from 
Gibberella fujikuroi (F6513), Glucose (G8270-100G) and Galactose (G5388-100G) was acquired 
from Sigma-Aldrich (St Louis, MO, USA). All other reagents and consumables were purchased 
from Merck (Darmstadt, Germany), unless otherwise stated.  
3.2. Cell culture and treatment protocol 
HepG2 cells were cultured in 25cm
3
 flasks in 5% CO2 at 37°C as described by Marriquin et al  
32
. 
Glucose free DMEM (Thermo-Fischer, A1443001) was supplemented as follows: 
Low glucose (GLUC): 5.5mM glucose, 5mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 10% fetal calf serum (FCS), 1mM sodium pyruvate, and 1% penstrepfungizone. High 
glucose (HG): 25mM glucose, 2 mM HEPES, 10% FCS, 1mM sodium pyruvate and 1% 
penstrepfungizone. Mannitol (19mM) was used as an osmotic control (OC). Galactose (GAL): 10 
mM galactose, 2mM glutamine, 5 mM HEPES, 10% FCS, 1mM sodium pyruvate, 1% 
penstrepfungizone. Free fatty acid (FFA): Sodium palmitate (Sigma, # P9767) was heat conjugated 
to fatty acid free bovine serum albumin (BSA) (1mM Sodium Palmitate/0.17mM BSA Solution) 
according to Schulz et al 
61
. Cells were treated with a final concentration of 0.25mM palmitate and a 
0.17mM BSA vehicle control (VC). These carbon sources were chosen to cover a broad range of 
metabolic backgrounds.   
FA (2 mg/mL) stock solution was prepared using sterile phosphate buffered saline (PBS, 0.1 M). 
This was then diluted in DMEM supplemented with the above mentioned energy substrates to final 
concentrations of 4, 63 and 250 µg/mL (0 µg/mL FA in control). These concentrations were 
selected by correlating the number of metabolically active cells to energy outputs using the WST-1 
(glycolysis) and Mitochondrial ToxGlo™ Assay (oxidative phosphorylation) data. Moreover, 
selecting doses capable of eliciting a biphasic response were hypothesised to provide a more 
complete characterization of FA toxicity.  
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A concentrated stock solution of oligomycin A and rotenone (10 mM) was prepared in Dimethyl 
sulphoxide (DMSO). This was diluted in media (0.1% v/v – benchmark DMSO concentration for in 
vitro experiments) to obtain final concentrations used in subsequent experiments. Sodium 
dichloroacetate (DCA, 1M) was dissolved in sterile PBS. This was then diluted in DMEM 
supplemented with the energy substrates of interest to a final concentration of 5mM. Cells were 
incubated for 6 hours (hrs) with test compounds to allow sufficient time for mitochondrial 
dysfunction/toxicity without overt cytotoxicity and cell death. All experiments were repeated at 
least three times (independently) in triplicate to validate results.  
3.3. Assessment of mitochondrial toxicity and cytotoxicity  
HepG2 cells were plated into a 96-well (15 000 cells, 200 µL/well) sterile white opaque 
luminometry plate. Following incubation with FA (0 – 1000 µg/mL, 37 °C, 5% CO2, 6 hrs) in 
GLUC, HG and GAL supplemented media the Mitochondrial ToxGlo Assay (Promega, Madison, 
WI, USA, G8000) was performed as per the manufacturers’ instructions. Briefly, cytotoxicity 
reagent was prepared by diluting bis-AAF-R110 substrate in assay buffer (5 µL/mL). The 
cytotoxicity reagent (20 µl/mL) was added to cells (100 µl media/well) and plate was shaken (30 
secs) and subsequently incubated at 37°C (30 min). The fluorescent signal indicating dead cell 
protease activity was measured at 485 nm/520–530 nm (Excitation/Emission) using a Modulus™ 
microplate luminometer (Turner Biosystems, Sunnyvale, USA). The plate was then left to 
equilibrate (room temperature, 10 min). ATPase reagent (100 µl) was added to each well, the plate 
was shaken (1 min) before the luminescence signal was measured using a Modulus™ microplate 
luminometer.  
3.4. Spectrophotometric quantitation of NAD(P)H using WST-1 
Cells were seeded (20 000 cells/well) in a 96 well microtitre plate. Cells were treated with varying 
concentrations of FA (0 – 1000 µg/mL, 37 °C, 5% CO2, 6 hrs) in triplicate (200 µL/well). The 
supernatant was then aspirated and 110 µl/well of a DMEM/WST-1 reagent solution (10:1) was 
added and incubated for 3 hrs (37 °C, 5% CO2). The absorbance of the colorimetric reaction was 
measured at a wavelength of 450 nm with a reference wavelength of 620 nm using a 




3.5. Acetyl-CoA quantification  
The PicoProbe Acetyl-CoA assay kit (Abcam 875460) was used to determine the levels of acetyl-
CoA. Briefly, cells (2 x 10
6
) were harvested and resuspended in assay buffer (500 µL) on ice. The 
homogenate was spun down (10,000xg, 10 min, 4°C) and the supernatant was collected and kept on 
ice. Acetyl-CoA standards (pMols), PicoProbe reagents and substrate mix were prepared and 
assayed as per manufacturer’s guidelines. Fluorescence was measured at 535/589 nm 
(Excitation/Emission) using the Modulus
TM
 microplate luminometer (Turner Biosystems, 
Sunnyvale, USA). The data is expressed as relative fluorescent units (RFU). 
3.6. Measurement of lactate 
Supernatants from cultured HepG2 cells were collected and lactate levels were assessed at a 
pathology laboratory (Global clinical and viral pathology, Amanzimtoti, Durban, South Africa).  
3.7. Protein quantification  
Protein expression was determined using western blots. Cytobuster™ Reagent (250 µL) (Novagen, 
San Diego, CA, USA, catalogue no. 71009) was used for protein extraction. Protein samples were 
quantified (bicinchoninic acid (BCA) assay)) and standardised to 1 mg/mL. The samples were then 
boiled (5 min) in Laemmli Sample buffer [dH20, 0.5 M Tris-HCl (pH 6.8), glycerol, 10% SDS, β-
mercaptoethanol, 1% bromophenol blue]. Prepared protein samples were electrophoresed on 
sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gels (4% stacking gel, 7.5% resolving gel) 
at 150V (Bio-Rad Mini PROTEAN Tetra-Cell System). The separated proteins transferred onto 
nitrocellulose membranes using the Trans-Blot Turbo Transfer system (standard mixed protein 
program, Bio-Rad). The membranes were blocked with 5% BSA in Tris Buffer Saline with tween 
20 (TTBS- NaCl, KCl, Tris, dH2O, 0.5% tween 20, pH 7.5). Membranes were incubated with 
primary antibody (1:1000 dilutions Table 1) overnight (4°C). The membranes were incubated (RT) 
with HRP-conjugated secondary antibody for 2 hrs (1:5,000 dilution). Protein bands were detected 
using the Clarity western ECL chemiluminescent substrate and images were captured with the 
ChemiDoc™ XRS+ Molecular Imaging System (Bio-Rad). Protein expression was normalised 
against house-keeping protein, HRP-conjugated β-actin (Sigma, A3854). Protein expression was 
analysed using Image Lab Software version 5.0 (Bio-Rad) and the results were expressed as relative 
band density (RBD). 
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Table 1: List of antibodies used to perform western blot experiments:  
Antibody Catalogue # 
Anti-Mitochondrial Pyruvate Dehydrogenase 
kinase 1 antibody (PDK1) 
Abcam (Ab207450) 
Anti-PKM2 antibody Abcam (Ab150377) 
Anti-Pyruvate Dehydrogenase E1α subunit 
(phospho S293) 
Abcam (Ab177461) 
Anti-HIF-1α antibody Sigma (H6536) 
3.8. RNA and qPCR  
RNA was isolated from control and FA treated HepG2 cells using an in house protocol 
62
. Total 
RNA was quantified (Nanodrop 2000, ThermoFischer), standardised (1000 ng/mL) and converted 
to complementary DNA (cDNA) using a commercially available kit (iScript™ cDNA Synthesis kit, 
Bio-Rad; catalogue no 107-8890). A 20 μL reaction volume containing 1μL RNA template, 4 μL 
5X iScript™ reaction mix, 1 μL iScript reverse transcriptase and nuclease free water was prepared. 
Thermocycler conditions were 25 °C for 5 min, 42 °C for 30 mins, 85 °C for 5 min and a final hold 
at 4 °C. 
 mRNA expression levels of genes involved in glycolysis and PDH inhibition was assessed (Table 
2) using the Sso Advanced™ Universal SYBR® Green Supermix (Bio-Rad, catalogue no. 172-
5271) and the CFX Touch™ Real Time PCR Detection System (Bio-Rad, Hercules, CA, USA). 
Conditions for PCR reactions: initial denaturation (95°C, 8 min), denaturation (95°C, 30 sec), 
annealing (variable: Table 2, 40 sec) and extension (72°C, 30 sec). Each measurement was done in 
triplicate and normalised against GAPDH which was run under the same conditions. Data was 
analysed using the Livak and Schmittgen (2001) method and represented as fold change relative to 









Table 2: Primer sequences and conditions used for gene expression studies: 
 
Sequence (5’-3’) Annealing temperature (°C) 
HIF-1α 
Forward: GAAC GTCG AAAAGTCT CG 




Forward: GTAC CATG CGGA GACC ATCA 
Reverse: GTAG GCGT TATC CAGC GTGA 
55 
LDHa 
Forward: GGTT GGTG CTGT TGCA TGG 
Reverse: TGCC CCAG CCGT GATA ATGA 
60 
PDK1 
Forward: CTGT GATA CGGA TCAG AAAC 
CG 




Forward: TCCA CCAC CCTG TTGC TGTA 





3.9. Intracellular ATP 
Intracellular ATP levels were measured using the ATP CellTitre Glo reagent (Promega, Madison, 
USA). Following treatment cells (20,000 cells/well in GLUC, HG and FFA supplemented DMEM) 
were seeded into a 96-well opaque polystyrene microtitre plate in triplicate. The ATP CellTitre Glo 
reagent (25 μL/well) was added to each sample and incubated in the dark for 30 min (RT). 
Thereafter, the luminescence was measured on a Modulus
TM
 microplate luminometer (Turner 
Biosystems, Sunnyvale, USA). The data is expressed as relative light units (RLU). 
3.10. Assessment of potential cytotoxicity (Biomass) 
HepG2 cells were cultured in 96-well plates (15,000 cells/well). After treatment with FA (described 
in 2.2) biomass was stained by decanting media and incubating attached cells with crystal violet 
solution (0.5% w/v) crystal violet/20% (v/v) Methanol) for 10 mins. After thorough washing with 
sterile deionised water to remove excess dye the plate was left to dry overnight. The dye was then 
solubilised with ethanol (100 µL/well) and the absorbance was quantified at 595 nm using a 
spectrophotometer (Bio-Tek uQuant, Winooski, VT, USA).    
3.11. Statistical analysis 
Statistical analysis was performed using one way ANOVA followed by Bonferroni test for multiple 
group comparison. Results are expressed as mean ± standard deviation (SD) unless otherwise 
stated. Differences with p<0.05 were considered statistically significant. 
Acknowledgements  
The authors wish to acknowledge Global Clinical and Viral Laboratory (Dr L Madurai and Mr D 
Nowrungsah), Durban, South Africa for sample analysis 
Funding sources: 
This work was supported by the German Academic Exchange Service-National research foundation 
of South Africa (DAAD-NRF) joint in-country scholarship programme (UID: 101837) and the 
College of Health Sciences (University of KwaZulu-Natal). 
Conflict of Interest:  






Availability of data 
The datasets generated and/or analysed during the current study are available from the 
corresponding author on reasonable request. 
 
Author Contributions 
NSA, SN and AC conceived and planned the experiments. NSA carried out the experiments. NSA, 
SN and AC contributed to the interpretation of the results. NSA prepared first draft of manuscript. 
All authors provided critical feedback and helped shape the research, analysis and manuscript.  
 
References 
1 Szabó, A. et al. Individual and Combined Effects of Fumonisin B1, Deoxynivalenol and 
Zearalenone on the Hepatic and Renal Membrane Lipid Integrity of Rats. Toxins 10, 4 
(2017). 
2 Rodrigues, I. & Naehrer, K. A three-year survey on the worldwide occurrence of 
mycotoxins in feedstuffs and feed. Toxins 4, 663-675 (2012). 
3 Smith, M.-C., Madec, S., Coton, E. & Hymery, N. Natural co-occurrence of mycotoxins in 
foods and feeds and their in vitro combined toxicological effects. Toxins 8, 94 (2016). 
4 Brown, D. W. et al. Identification of a 12-gene fusaric acid biosynthetic gene cluster in 
Fusarium species through comparative and functional genomics. Molecular plant-microbe 
interactions 28, 319-332 (2015). 
5 Bacon, C., Porter, J., Norred, W. & Leslie, J. Production of fusaric acid by Fusarium 
species. Applied and Environmental Microbiology 62, 4039-4043 (1996). 
6 Streit, E. et al. Multi-mycotoxin screening reveals the occurrence of 139 different 
secondary metabolites in feed and feed ingredients. Toxins 5, 504-523 (2013). 
7 Hirai, T., Fukushima, K., Kumamoto, K. & Iwahashi, H. Effects of some naturally 
occurring iron ion chelators on in vitro superoxide radical formation. Biological trace 
element research 108, 77-85 (2005). 
8 Yin, E. S. et al. Fusaric acid induces a notochord malformation in zebrafish via copper 
chelation. Biometals 28, 783-789 (2015). 
 107 
 
9 Singh, V. K., Singh, H. B. & Upadhyay, R. S. Role of fusaric acid in the development of 
‘Fusarium wilt’symptoms in tomato: Physiological, biochemical and proteomic 
perspectives. Plant Physiology and Biochemistry 118, 320-332 (2017). 
10 Selim, M. E. & El-Gammal, N. A. Role of fusaric acid mycotoxin in pathogensis process of 
tomato wilt disease caused by Fusarium oxysporum. Journal of Bioprocessing & 
Biotechniques 5, 1 (2015). 
11 Wang, H. & Ng, T. Pharmacological activities of fusaric acid (5-butylpicolinic acid). Life 
sciences 65, 849-856 (1999). 
12 Porter, J. K., Bacon, C. W., Wray, E. M. & Hagler, W. M. Fusaric acid in Fusarium 
moniliforme cultures, corn, and feeds toxic to livestock and the neurochemical effects in the 
brain and pineal gland of rats. Natural Toxins 3, 91-100 (1995). 
13 Malovrh, T. & Jakovac-Strajn, B. Feed contaminated with Fusarium toxins alter 
lymphocyte proliferation and apoptosis in primiparous sows during the perinatal period. 
Food and Chemical Toxicology 48, 2907-2912 (2010). 
14 Bacon, C. W., Porter, J. K. & Norred, W. P. Toxic interaction of fumonisin B 1 and fusaric 
acid measured by injection into fertile chicken egg. Mycopathologia 129, 29-35 (1995). 
15 Swamy, H., Smith, T., Cotter, P., Boermans, H. & Sefton, A. Effects of feeding blends of 
grains naturally contaminated with Fusarium mycotoxins on production and metabolism in 
broilers. Poultry science 81, 966-975 (2002). 
16 Reddy, R., Larson, C., Brimer, G., Frappier, B. & Reddy, C. Developmental toxic effects of 
fusaric acid in CD1 mice. Bulletin of environmental contamination and toxicology 57, 354-
360 (1996). 
17 Abdul, N. S., Nagiah, S. & Chuturgoon, A. A. Fusaric acid induces mitochondrial stress in 
human hepatocellular carcinoma (HepG2) cells. Toxicon 119, 336-344 (2016). 
18 Devnarain, N., Tiloke, C., Nagiah, S. & Chuturgoon, A. A. Fusaric acid induces oxidative 
stress and apoptosis in human cancerous oesophageal SNO cells. Toxicon 126, 4-11 (2017). 
19 Dhani, S., Nagiah, S., Naidoo, D. B. & Chuturgoon, A. A. Fusaric Acid immunotoxicity 
and MAPK activation in normal peripheral blood mononuclear cells and Thp-1 cells. 
Scientific Reports 7, 3051 (2017). 
20 Ghazi, T., Nagiah, S., Tiloke, C., Sheik Abdul, N. & Chuturgoon, A. A. Fusaric Acid 
Induces DNA Damage and Post‐Translational Modifications of p53 in Human 




21 Telles-Pupulin, A., Salgueiro-Pagadigorria, C., Bracht, A. & Ishii-Iwamoto, E. L. Effects of 
fusaric acid on rat liver mitochondria. Comparative Biochemistry and Physiology Part C: 
Pharmacology, Toxicology and Endocrinology 120, 43-51 (1998). 
22 Gao, A. W., Cantó, C. & Houtkooper, R. H. Mitochondrial response to nutrient availability 
and its role in metabolic disease. EMBO molecular medicine 6, 580-589 (2014). 
23 Goodpaster, B. H. & Sparks, L. M. Metabolic flexibility in health and disease. Cell 
metabolism 25, 1027-1036 (2017). 
24 Liberti, M. V. & Locasale, J. W. The Warburg effect: how does it benefit cancer cells? 
Trends in biochemical sciences 41, 211-218 (2016). 
25 Seyfried, T. N. & Shelton, L. M. Cancer as a metabolic disease. Nutrition & metabolism 7, 
7 (2010). 
26 Metallo, C. M. & Vander Heiden, M. G. Metabolism strikes back: metabolic flux regulates 
cell signaling. Genes & development 24, 2717-2722 (2010). 
27 Metallo, C. M. & Vander Heiden, M. G. Understanding metabolic regulation and its 
influence on cell physiology. Molecular cell 49, 388-398 (2013). 
28 Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nature 
Reviews Cancer 11, 85 (2011). 
29 Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews 
Cancer 8, 705 (2008). 
30 Serrano, J. C., Cassanye, A., Martín-Gari, M., Granado-Serrano, A. B. & Portero-Otín, M. 
Effect of dietary bioactive compounds on mitochondrial and metabolic flexibility. Diseases 
4, 14 (2016). 
31 Europa, A. F., Gambhir, A., Fu, P. C. & Hu, W. S. Multiple steady states with distinct 
cellular metabolism in continuous culture of mammalian cells. Biotechnology and 
bioengineering 67, 25-34 (2000). 
32 Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D. & Will, Y. Circumventing the 
Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 
cells to mitochondrial toxicants. Toxicological Sciences 97, 539-547 (2007). 
33 Stanton, R. C. Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival. IUBMB life 
64, 362-369 (2012). 
34 Zhu, A., Romero, R. & Petty, H. R. An enzymatic colorimetric assay for glucose-6-
phosphate. Analytical biochemistry 419, 266-270 (2011). 
 109 
 
35 Pereira, C. V., Oliveira, P. J., Will, Y. & Nadanaciva, S. Mitochondrial bioenergetics and 
drug-induced toxicity in a panel of mouse embryonic fibroblasts with mitochondrial DNA 
single nucleotide polymorphisms. Toxicology and applied pharmacology 264, 167-181 
(2012). 
36 Kamalian, L. et al. The utility of HepG2 cells to identify direct mitochondrial dysfunction 
in the absence of cell death. Toxicology in vitro 29, 732-740 (2015). 
37 Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg 
effect: the metabolic requirements of cell proliferation. science 324, 1029-1033 (2009). 
38 MIZUGAKI, M. et al. Chain elongation of fusaric acid and related compounds in rat liver. 
The Journal of Biochemistry 99, 469-476 (1986). 
39 Korotchkina, L. G. & Patel, M. S. Probing the mechanism of inactivation of human 
pyruvate dehydrogenase by phosphorylation of three sites. Journal of Biological Chemistry 
276, 5731-5738 (2001). 
40 Fan, J. et al. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking 
substrate binding and promotes the Warburg effect. Journal of Biological Chemistry 289, 
26533-26541 (2014). 
41 Mariño, G. et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Molecular cell 
53, 710-725 (2014). 
42 Zhang, Y. et al. Regulation of hepatic pyruvate dehydrogenase phosphorylation in offspring 
glucose intolerance induced by intrauterine hyperglycaemic. Oncotarget 8, 15205 (2017). 
43 Dupuy, F. et al. PDK1-dependent metabolic reprogramming dictates metastatic potential in 
breast cancer. Cell metabolism 22, 577-589 (2015). 
44 Kolobova, E., Tuganova, A., Boulatnikov, I. & Popov, K. M. Regulation of pyruvate 
dehydrogenase activity through phosphorylation at multiple sites. Biochemical Journal 358, 
69 (2001). 
45 Ward, P. S. & Thompson, C. B. Metabolic reprogramming: a cancer hallmark even warburg 
did not anticipate. Cancer cell 21, 297-308 (2012). 
46 Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors 
for oxygen-dependent proteolysis. Nature 399, 271 (1999). 
47 Kubis, H.-P., Hanke, N., Scheibe, R. J. & Gros, G. Accumulation and nuclear import of 
HIF1 alpha during high and low oxygen concentration in skeletal muscle cells in primary 




48 Milosevic, J. et al. Non-hypoxic stabilisation of hypoxia-inducible factor alpha (HIF-α): 
Relevance in neural progenitor/stem cells. Neurotoxicity research 15, 367-380 (2009). 
49 Iwahashi, H., Kawamori, H. & Fukushima, K. Quinolinic acid, α-picolinic acid, fusaric 
acid, and 2, 6-pyridinedicarboxylic acid enhance the Fenton reaction in phosphate buffer. 
Chemico-biological interactions 118, 201-215 (1999). 
50 Golias, T. et al. Hypoxic repression of pyruvate dehydrogenase activity is necessary for 
metabolic reprogramming and growth of model tumours. Scientific reports 6, 31146 (2016). 
51 Kim, J.-w., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of 
pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to 
hypoxia. Cell metabolism 3, 177-185 (2006). 
52 Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A. & Gilbert, E. R. The pivotal role 
of pyruvate dehydrogenase kinases in metabolic flexibility. Nutrition & metabolism 11, 10 
(2014). 
53 Wong, C. C.-L. et al. Switching of pyruvate kinase isoform L to M2 promotes metabolic 
reprogramming in hepatocarcinogenesis. PloS one 9, e115036 (2014). 
54 Dong, T. et al. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation 
of HIF-1α and Bcl-xL in culture. Biomedicine & pharmacotherapy 69, 277-284 (2015). 
55 Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible 
factor 1. Cell 145, 732-744 (2011). 
56 Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1α activity and IL-1β 
induction and is a critical determinant of the warburg effect in LPS-activated macrophages. 
Cell metabolism 21, 65-80 (2015). 
57 Edmunds, L. R. et al. c-Myc programs fatty acid metabolism and dictates acetyl-CoA 
abundance and fate. Journal of Biological Chemistry 289, 25382-25392 (2014). 
58 Fantin, V. R., St-Pierre, J. & Leder, P. Attenuation of LDH-A expression uncovers a link 
between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer cell 9, 425-
434 (2006). 
59 Lu, H., Forbes, R. A. & Verma, A. Hypoxia-inducible factor 1 activation by aerobic 
glycolysis implicates the Warburg effect in carcinogenesis. Journal of Biological Chemistry 
277, 23111-23115 (2002). 
60 Calabrese, E. J. & Baldwin, L. A. The hormetic dose-response model is more common than 
the threshold model in toxicology. Toxicological Sciences 71, 246-250 (2003). 
 111 
 
61 Schulz, N., Kluth, O., Jastroch, M. & Schürmann, A. Minor role of mitochondrial 
respiration for fatty-acid induced insulin secretion. International journal of molecular 
sciences 14, 18989-18998 (2013). 
62 Chuturgoon, A., Phulukdaree, A. & Moodley, D. Fumonisin B1 induces global DNA 
hypomethylation in HepG2 cells–An alternative mechanism of action. Toxicology 315, 65-
69 (2014). 
63 Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time 









Interactomic and molecular mechanisms of Fusaric acid induced mitochondrial sirtuin 
aberrations in glycolytically and oxidatively poised HepG2 liver cells  
 
Chapter 4 underlined the induction of metabolic inflexibility by FA in HepG2 cells. Mitochondrial 
SIRTs are regarded as energy sensors and at the forefront of metabolic regulation and stress 
responses. In this chapter the inhibitory effects of FA on SIRTs 3 and 5 activities were determined 
using in silico methods. Furthermore, the expression profiles of these mitochondrial SIRTs were 
analysed along with their possible regulatory mechanisms at the transcriptional, post-transcriptional 
and translational levels. Fusaric acid strongly associates with SIRTs and downregulates their 
expression profiles in both glycolytic and OxPhos primed cells.  
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Fusaric acid (FA) is a ubiquitous yet neglected mycotoxin. The toxicity of FA is associated with 
mitochondrial dysfunction and oxidative stress. Sirtuins (SIRTs) are key mediators of cell stress 
responses through deacetylation of antioxidant, mitochondrial maintenance and energy metabolism 
proteins. Dietary bioactive compounds have profound effects on SIRT activity, however little is 
known regarding common foodborne toxins and SIRTs. In this study the interaction of FA with 
mitochondrial SIRTs – SIRT3 and SIRT5, were firstly studied by molecular docking. Thereafter we 
substantiated the in silico findings by investigating the effect of FA on expression profiles of SIRT3 
and SIRT5, and transcriptional and post-transcriptional regulators, PGC-1α and miRNA-30c using 
western blots and qPCR in vitro. FA was predicted to bind to the active site of SIRT3 and SIRT5 
having implications for biological activity. Furthermore, protein expression of SIRT3 and SIRT5 
was down-regulated despite elevated mRNA levels. Further experimentation revealed post-
transcriptional regulation of both SIRTs as evidenced by elevated miRNA-30c despite induction of 
PGC-1α. This study highlights the potential of a diet contaminated with FA to dysregulate 














1. Introduction  
Mitochondria are essential organelles that regulate diverse aspects of cell biology and homeostasis, 
and are central to cellular energy metabolism and fuel utilisation. 
1-3
. Mitochondrial dysfunction is 
associated with metabolic inflexibility and is implicated in the development of several metabolic 
diseases including cancer 
4
 and insulin resistance 
5
. To maintain mitochondrial integrity, these 
organelles are equipped with innate protective mechanisms that are systematically and 
biochemically linked to metabolic processes and energy substrate availability 
6-9
.   
The mammalian family of sirtuins (SIRTs) has attracted major interest given their links to protein 
acetylation and diseases relating to metabolism and aging 
10
. The SIRTs are integral post-
translational regulators of protein activity in response to nutrient availability and stressors through 
deacetylation of lysine residues 
11-13
. Sirtuin 3 has been shown to directly deacetylate and activate 
numerous mitochondrial proteins involved in the tricarboxylic acid (TCA) cycle, oxidative 
phosphorylation (OxPhos), fat metabolism and stress responses 
12, 14-17
. Knockout models of SIRT3 
exhibit hyperacetylation of mitochondrial proteins highlighting its strong deacetylase activity 
18
. 
SIRT5 was recently described to more efficiently demalonylate or desuccinylate its substrates due 
to the presence of an Arg105 residue and Tyr102 residue in its pocket 
14
, this primary mitochondrial 
dessucinylase is reported to regulate the urea cycle by targeting carbamoyl phosphate synthase 1 
(the rate limiting enzyme of the urea cycle) 
19
. Sirtuin 5 has also been shown to influence 
mitochondrial metabolism through succinylation of the pyruvate dehydrogenase complex and 
succinate dehydrogenase 
20
. Pathway analyses of targets of SIRT5 show hypersuccinylation in 
knockout mice and subsequent perturbations to fatty acid oxidation and ketone body production 
21
.  
Peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α) is a transcriptional 
co-activator vital in maintenance of mitochondrial function, protection and biogenesis 
12, 22-24
. The 
elucidation of the transcriptional regulation of diverse stress and metabolic pathways have led to the 
discovery of mitochondrial SIRTs 3 and 5 as putative downstream target genes of PGC-1α 13. These 
mitochondrial SIRTs are also regulated at the post-transcriptional level by microRNAs (miRNA), 




The biochemical activation of SIRT activity is dependent on NAD
+ 
and release of nicotinamide 
(NAM) and O-acetyl ADP ribose as by-products, and NAM itself can inhibit SIRT activity 
26, 27
. 
Thus, SIRT activity is linked to cellular energy and redox status 
28
. Dietary bioactive compounds 
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are known to have profound effects on sirtuin activity, however very little is known regarding 
common foodborne toxins and their roles in SIRT regulation. 
Mycotoxins are fungal secondary metabolites that adversely affect humans, animals and plants and 
their contamination of food and feed presents a significant problem to food security 
29, 30
. 
Mycotoxins are a structurally diverse group of compounds that display structural similarities to 
biologically relevant molecules, and this contributes significantly to their toxic mechanisms of 
action 
31
. The Fusarium mycotoxin, fusaric acid (FA) is a common contaminant of maize with a 
reported contamination rate of up to 13,593 µg/kg sample 
32, 33
. Despite its ubiquitous presence this 
mycotoxin is neglected in terms of research. Several studies have highlighted the synergistic and 
additive effects of FA and co-produced mycotoxins in animal models 
34-36
. More recent single toxin 
analyses in human cell lines indicate genotoxicity, cytotoxicity, deregulation of cell signalling and 
activation of cell death machinery 
37-40
.  
Canonical FA toxicity is ascribed to oxidative stress, cell death and mitochondrial dysfunction 
39-41
. 
FA is regarded as a putative mitochondrial toxin that inhibits enzymes of the TCA cycle and 
OxPhos 
42
. Furthermore FA was shown to induce mitochondrial stress and impair mitochondrial 
biogenesis as well as inhibiting ATP synthesis 
39, 42
. However, the full effects of mitochondrial 
perturbations by this niacin related mycotoxin has yet to be fully elucidated.  
Many highly proliferative cells almost exclusively utilise glycolysis as a means to generate ATP 
despite the presence of functional mitochondria. Such anaerobically poised cells are resistant to 
mitochondrial toxins, elevated rates of glycolysis act as a compensatory measure to mitochondrial 
ATP generation impairment. In contrast, cells grown in galactose are forced to rely on 
mitochondrial OxPhos to meet their energy demands 
43
. Consistent with this methodology we 
identified alterations to NAD
+
 levels in glycolytic and aerobic poised HepG2 liver cells and 
elucidate the impact of FA on mitochondrial SIRT 3 and 5 expression, at the transcription and 
translation levels.  
2. Methods and materials  
2.1. Reagents   
The HepG2 liver cell line was acquired from Highveld Biologicals (Johannesburg, SA). Fusaric 
acid (isolated from Gibberella fujikuroi- F6513), Glucose (G8270-100G) and Galactose (G5388-
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100G) was acquired from Sigma-Aldrich (St Louis, MO, USA). Western blot reagents were 
purchased from Bio-Rad (Hercules, CA, USA). All other reagents and consumables were purchased 
from Merck (Darmstadt, Germany), unless otherwise stated.  
2.2. Molecular docking (in silico) 
Molecular docking was performed to visualise the orientation of ligand in the active site pocket of 
AIRT3 and SIRT5 to understand the mechanism of substrate/inhibitor selectivity 
44
. Three-
dimensional structures of SIRT3 and SIRT5 were taken from the Protein Data Bank (PDB codes 
4v1c and 5xhs respectively) 
45
. The chemical structure of FA was drawn using sketch molecules 
module of BIOVIA Discovery Studio (Dassault Systèmes, San Diego). The hydrogen was initially 
added to optimise the geometry of ligands through molecular mechanics using universal force fields 
and steepest descent algorithm present in Avogadro tools 
46
. The docking confirmed the binding 
affinity of FA with SIRT3 and SIRT5. Fusaric acid  was docked by defining the grid box with 
spacing of 1 Å and size of 30 × 30 × 30 pointing in x, y and z directions around the SIRT3 and 
SIRT5 active sites following the standard docking protocol 
47, 48
 using AutoDockTools and 
AutoDockVina 
49
 with default docking parameters. The Lamarckian Genetic Algorithm was used as 
the search algorithm with default parameter values. The most suitable docked conformation was 









 were used for the 
visualisation and structure analysis of docked complex. 
2.3. Cell culture and treatment protocol 
HepG2 cells were cultured in 25cm
3
 flasks in 5% CO2 at 37°C as described by Marriquin et al  
(2007) 
43
. Glucose free DMEM (Thermo-Fischer, A1443001) was supplemented as follows: 
Low glucose (GLUC): 5.5mM glucose, 5mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 10% foetal calf serum (FCS), 1mM sodium pyruvate, and 1% penstrepfungizone. High 
glucose (HG): 25mM glucose, 2 mM HEPES, 10% FCS, 1mM sodium pyruvate and 1% 
penstrepfungizone. Mannitol (19mM) was used as an osmotic control (OC). Galactose (GAL): 10 




FA (2 mg/mL) stock solution was prepared using sterile phosphate buffered saline (PBS, 0.1M). 
This was then diluted in DMEM supplemented with the above mentioned carbon sources to final 
concentrations of 4, 63 and 250 µg/mL (0 µg/mL FA in control) for 6 hours. These concentrations 
were selected by correlating the number of metabolically active cells to energy outputs using the 
WST-1 (glycolysis) and Mitochondrial ToxGlo™ Assay (oxidative phosphorylation) data (Sheik 
Abdul 2018, submitted to Scientific reports, SREP-18-28513, unpublished data). All experiments 






/NADH Assay Kit (ab 65348, Abcam) was used to quantify intracellular NAD
+ 
levels, 
according to the manufacturer’s recommendations with no amendments. A standard curve was 
generated and used to extrapolate total NAD
+ 
(pmol) in glycaemic and aglycaemic culture 
conditions.  
2.5. Protein quantification   
Protein expression was determined using western blots. Cytobuster™ Reagent (250 µL) (Novagen, 
San Diego, CA, USA, catalogue no. 71009) was used for protein extraction. Protein samples were 
quantified (bicinchoninic acid (BCA) assay)) and standardised to 1 mg/mL. The samples were then 
boiled (5 min) in Laemmli Sample buffer [dH20, 0.5 M Tris-HCl (pH 6.8), glycerol, 10% SDS, β-
mercaptoethanol, 1% bromophenol blue]. Prepared protein samples were electrophoresed on 
sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gels (4% stacking gel, 7.5% resolving gel) 
at 150V (Bio-Rad Mini PROTEAN Tetra-Cell System). The separated proteins transferred onto 
nitrocellulose membranes using the Trans-Blot Turbo Transfer system (standard mixed protein 
program, Bio-Rad). The membranes were blocked with 5% BSA in Tris Buffer Saline with tween 
20 (TTBS- NaCl, KCl, Tris, dH2O, 0.5% tween 20, pH 7.5). Membranes were incubated with 
primary antibody (1:1000 dilutions Table 1) overnight (4°C). The membranes were incubated (RT) 
with HRP-conjugated secondary antibody for 2 hr (1:5,000 dilution). Protein bands were detected 
using the Clarity western ECL chemiluminescent substrate and images were captured with the 
ChemiDoc™ XRS+ Molecular Imaging System (Bio-Rad). Protein expression was normalised 
against house-keeping protein, HRP-conjugated β-actin (Sigma, A3854). Protein expression was 
analysed using Image Lab Software version 5.0 (Bio-Rad) and the results were expressed as relative 
band density (RBD).  
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Table 1: List of antibodies used to perform western blot experiments:  
Antibody Catalogue # 
PGC-1α Cell Signalling Technology (#2178) 
SIRT3 Abcam (#86671) 
SIRT5 Abcam (#13697) 
Phospho-eiF2α (Ser51)  Cell Signalling Technology (#3597) 
 
2.6. RNA and qPCR  
RNA was isolated from control and FA treated HepG2 cells using an in house protocol 
55
. Total 
RNA was quantified (Nanodrop 2000, ThermoFischer), standardised (1000 ng/mL) and converted 
to complementary DNA (cDNA) using a commercially available kit (iScript™ cDNA Synthesis kit, 
Bio-Rad; catalogue no 107-8890). A 20μL reaction volume containing 1μL RNA template, 4μL 5X 
iScript™ reaction mix, 1μL iScript reverse transcriptase and nuclease free water was prepared. 
Thermocycler conditions were 25°C for 5 min, 42°C for 30 min, 85°C for 5 min and a final hold at 
4 °C. Transcript expression levels of mitochondrial specific SIRT genes (Table 2) were quantified 
using the SsoAdvanced™ Universal SYBR® Green Supermix (Bio-Rad, catalogue no. 172-5271) 
and the CFX Touch™ Real Time PCR Detection System (Bio-Rad, Hercules, CA, USA). 
Conditions for PCR reactions: initial denaturation (95°C, 8 min), denaturation (95°C, 30 sec), 
annealing (Table 2, 40 sec) and extension (72°C, 30 sec). Each measurement was done in triplicate 
and normalised against GAPDH which was run under the same conditions. Data was analysed using 
















Forward: 5’-CGGC TCTA CACG AGAA CATC-3’ 
Reverse: 5’-CAGC GGCT CCCC AAAG GAAC AC-3’ 
57 
SIRT5 
Forward: 5’-CGAA ACCA GCCT GAA-3’ 
Reverse: 5’-TTCT CCAA ACCA CACG ACGT-3’ 
57 
GAPDH 
Forward: 5’-TCCA CCAC CCTG TTGC TGTA-3’ 




2.7. MicroRNA 30c analysis 
A standard miRNA target prediction tool (TargetScan) was used to search for potential candidate 
miRNAs that may regulate the mitochondrial SIRTs. MiRNA 30c (miR-30c) was predicted to 
regulate both SIRT3 and SIRT5. The cDNA for miRNA analysis was prepared by using a 10µl 
reaction mix of the miScript II RT kit [cat. No. 240 MS00003528 (5× miScript HiSpec Buffer, 
miScript Reverse Transcriptase Mix 10× miScript 241 Nucleics Mix; Qiagen)] as per 
manufacturer’s instructions. MiR-30c levels were then quantified using the miScript Primer Assay 
(Qiagen). Data was normalised against human RNA U6 small nuclear 2 (RNU6-2) and analysed 








2.8. Statistical analysis 
Statistical analysis was performed using one way ANOVA followed by Bonferroni test for multiple 
group comparison. Results are expressed as mean ± standard deviation (SD) unless otherwise 
stated. Differences with p<0.05 were considered statistically significant. 
3. Results  
3.1. Docked complex interactions of ligand FA and target enzymes SIRT3 and SIRT5 
Computational methods such as molecular docking are reliable for the prediction of binding modes 
and affinities of ligands and enzymes. We first determined if FA could act as a ligand for SIRT3. 
An analysis of the docked complex of SIRT3 revealed significant interactions of FA with the 
enzyme. The total free energy of binding was estimated to be -6.4 kcal/mol. FA readily interacted 
with the target protein through a variety of interactions including hydrogen bonding, p-sigma 
bonding, alky bonding and metal chelation of the zinc atom (Figure 1A). Similarly, FA formed 
close interactions to residues of SIRT5 as shown by conventional hydrogen bonding, pi cation 
bonding and alkyl bonding. The binding efficiency of FA to SIRT5 was relatively strong with an 







    
 
 





 is differentially regulated by FA in a concentration dependent manner 
NAD
+ 
is a necessary co-substrate for the biochemical activity of SIRTs.  The involvement of FA in 
NAD
+ 
perturbations was assessed using a colorimetric assay. Under low glucose (GLUC) and 
OxPhos (GAL) primed conditions FA significantly elevated NAD
+ 
levels at 4 and 63 µg/mL (Figure 
2A and C).  NAD
+ 
levels in HG cells showed a remarkable increase only at 63 µg/mL followed by a 











Figure 2: FA alters NAD
+
 concentrations in a dose and energy substrate dependent manner. The 
results are expressed relative to the control ± SD (n=3).  
**p<0.01, *p<0.05 vs control 
 
3.3 FA suppresses SIRT3 protein expression despite elevated transcription 
FA induces oxidative stress as its canonical mechanism of toxicity. SIRT3 is a stress response 
deacetylase that activates anti-oxidant defences. We therefore examined the influence of FA on 
SIRT3 expression profiles.  
FA, at all tested concentrations, significantly decreased SIRT3 protein levels. This decrease was 
dose dependent with the 250 µg/mL FA exerting the greatest effect across all conditions tested (Fig 
3A-C). In contrast FA significantly elevated SIRT3 mRNA expression except at the highest dose of 
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FA (Fig 3D-F). These results were independent of the energy substrate present in the media 
indicating that SIRT3 is a putative target of FA.    
 
Figure 3: Western blot analysis of SIRT3 revealed significant dose dependent decreases after 
stimulation with FA (A-C). In contrast SIRT3 mRNA levels were significantly elevated (D-F). The 
results are expressed relative to the control ± SD (n=3).     
***p< 0.001, **p<0.01, *p<0.05 vs control 
 
3.4. SIRT5 protein expression is downregulated in spite of higher transcript levels in response to FA 
stimulation. 
We then investigated the expression profile of the mitochondrial desuccinylase, SIRT5. FA 
significantly decreased the protein levels of SIRT5 under glycaemic conditions (Fig 3A and B). In 
OxPhos primed cells the lowest concentration of FA elevated SIRT5 expression levels while at 250 
µg/mL a significant decline in expression was noted (Fig 4C). This observation is in sharp contrast 
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with transcript levels as we noted an increased expression of SIRT5 mRNA across all energy 


















Figure 4: SIRT5 protein expression was consistently and significantly decreased under glycaemic 
conditions (A-C). This was in contrast to the mRNA levels which showed significant elevation 
across all tested energy substrates. The results are expressed relative to the control ± SD (n=3).     
***p< 0.001, **p<0.01, *p<0.05 vs control 
 
3.5. SIRT3 and SIRT5 transcriptional and translational machinery is dysregulated by FA.  
Both SIRT3 and SIRT5 are downstream targets of PGC-1α. Stimulation of PGC-1α has been shown 
to elevate SIRT3 and SIRT5 protein expression and mRNA.  
Cells cultured under low glucose (GLUC) showed a significant decrease to in PGC-1α expression at 
the lowest and highest FA concentrations whilst 63 µg/mL stimulated expression significantly (Fig 
5A). Cells supplemented with high glucose (HG) showed significantly decreased PGC-1α 
expression regardless of FA concentration when compared to the control (Fig 5B). In contrast, FA 
dose dependently increased the expression of PGC-1α in OxPhos primed cells (GAL, Fig 5C).  
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Phosphorylation of the eukaryotic initiation factor 2 (eIF2) α subunit is a well-documented 
mechanism to decrease protein synthesis. We explored the potential of FA to dysregulate the 
phosphorylation status of eIF2α as a marker of defective translation. We found that FA enhanced 
phosphorylation of eIF2α in cells poised to undergo glycolysis (Fig 5D and E) and OxPhos (Fig 






















Figure 5: FA dysregulates transcriptional (PGC-1α; A-C) and translational (p-eIF2α; D-E) 
machinery of SIRT3 and SIRT5. The results are expressed relative to the control ± SD (n=3).     






3.6. FA elevates MiRNA 30c in glycolytic and OxPhos primed cells  
Using standard predicts miRNA target tools (TargetScan) we identified MiRNA 30c as a common 
post-transcriptional regulator of SIRT3 and SIRT5 (Fig 6A). Profiling of MiRNA 30c revealed FA 
to up-regulate its expression particularly at higher concentrations and across all tested energy 
substrates (Fig 6B-D).  
 
Figure 6: Sequence homology alignment between SIRT3 and SIRT5 and predicted target sequence 
of miR-30c (A). FA up-regulates miR-30c at higher concentrations (B-D). The results are expressed 
relative to the control ± SD (n=3).     




The canonical mechanism of FA toxicity is associated with oxidative stress and mitochondrial 
dysfunction 
39, 41, 42, 57
; however the notion that FA is a putative mitochondrial toxin is yet to be 
clarified. Mitochondrial SIRTs are NAD
+ 
dependent enzymes implicated in several physiological 
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and disease states 
58





Sirtuins, a family of seven deacetylases, share a highly conserved catalytic core and differ only in 
their N- and C-terminal domains. The catalytic core is made up of two domains, a large Rossman 
fold and a smaller zinc binding domain 
61
. The acetylated protein and the NAD
+
 co-factor bind in a 
cleft between the two domains. The enzymatic reaction yields a deacetylated protein product and 
NAM, a competitive inhibitor of SIRT activity 
62
. In this study, using in silico molecular docking, 
we show that FA directly interacts with SIRT3 and SIRT5 through several chemical bond 
interactions at the active pocket (Fig 1A and 1B) resulting in ligand-enzyme docked conformations 
that decrease biological activity. Acylation of lysine is an important protein modification with 
SIRT3 and SIRT5 displaying distinct acyl substrate preferences which have evolved to operate in 
unique physiological processes 
63
. The diverse deacylation activities for SIRTs are related to 
differences in the amino acids present in the acyl binding pocket. While SIRT3 is a robust 
deacetylase, SIRT5 is recognised as a desuccinylase/demalonylase enzyme. The preference for 
succinyl and malonyl groups by SIRT5 is attributed to the presence of an arginine residue (Arg105) 
and tyrosine residue (Tyr102) in the acyl pocket, thus making it a weaker deacetylase than SIRT3 
64
.   
 
The synthesis and catabolism of NAD plays a vital role in the regulation of NAD-consuming 
enzymes, such as SIRTs. Several dehydrogenase enzymes of the TCA cycle reduce NAD
+
 to 
NADH; that is needed to drive ATP production via the electron transport chain and OxPhos. 
Mitochondrial function and acetylation status is highly dependent on the limiting levels of NAD
+
  
65. Fusaric acid is known to inhibit α-ketoglutarate dehydrogenase 42, a key TCA cycle enzyme that 
reduces NAD
+ to NADH during the conversion of α-ketoglutarate to succinyl-CoA. Our 
observations of elevated NAD
+ 
(Fig 2), especially in cells poised to undergo OxPhos, could be a 
direct result of this inhibitory effect as NAD
+ 
can no longer be reduced to NADH. These results are 
in agreement with our previous study, which showed FA to dysregulate reducing equivalent 




The universal SIRT regulators, NAD
+ 
and NAM, are essential for mitochondrial acetylome 
maintenance 
66, 67
. Both SIRT3 and SIRT5 share a similar affinity for NAD
+
 as a co-substrate. 
Structural and activity data, however, suggest differential sensitivities of SIRTs to NAM inhibition, 
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with SIRT3 being more sensitive than SIRT5 
68
. Nicotinamide is niacin related, pyridine derivative 
and is structurally similar to FA. A recent study revealed that novel bioisosteric analogues of NAM 
can inhibit SIRT3 activity 
69
. We speculate that FA acts as a competitive inhibitor and, once bound 
to the co-substrate site, decreases SIRT activity by preventing NAD
+
 catalysis. We have previously 
shown that FA inhibits SIRT3 activity in a similar manner to NAM 
39
. Taken together, FA may be 
more selective for SIRT3 over SIRT5 as evidenced by a higher binding affinity (S1) and differential 
sensitivities to NAM inhibition.  
 
It is important to underpin the difference between enzyme expression and activity. The expression 
levels of SIRTs are regulated at several levels.  Analysis of SIRT3 and SIRT5 protein expression 
revealed down-regulation at the translated level (Fig 3A-C and 4A-C) but elevated transcript levels 
(Fig 3D-F and 4D-F). The net balances of forces often determine whether a protein will be its native 
folded conformation or denatured 
70
. The protein stability of SIRT3 and SIRT5 is dependent on zinc 
ions co-ordinated by four cysteine residues 
61, 71
, FA being an established chelator of divalent 
cations 
41, 72
 can interact with zinc causing loss of protein stability and structural integrity.  
 
At the transcriptional level, both SIRT3 and SIRT5 are regulated by PGC-1α. This co-transcription 
factor up-regulates the mRNA levels of SIRT3 
12
 and SIRT5 
13
. Moreover, SIRT3 regulates PGC-1α 
activity, forming a positive feedback loop linking together oxidative stress, metabolism and 
mitochondrial function 
12
. It is well established that PGC-1α is up-regulated during mitochondrial 
stress conditions as mechanism of cell defence 
73, 74
. We show that FA dysregulates the expression 
of PGC-1α in a substrate dependent manner (Fig 5 A-C). Fusaric acid induced a biphasic response 
in cells cultured under low glucose conditions (Fig5 A) but elevated the expression of PGC-1α at all 
tested concentrations in OxPhos primed cells (Fig 5C). Cells supplemented with GAL as the energy 
substrate or limited glucose supply is more sensitive to mitotoxins and induce a greater response to 
overcome mitochondrial stress and its implications such as oxidative stress. A recent study by 
Gounden et al (2014) linked high glucose levels to elevated expression of PGC-1α expression 75. 
However, FA significantly decreased the expression of PGC-1α. These results show FA initiates 
cytoprotective mechanism to the putative mitochondrial toxin FA through activation of the SIRT 
transcription pathway and concomitant increase to SIRT3 and SIRT5 mRNA levels, suggesting 




Protein synthesis is often inhibited in cells undergoing stress by enhanced phosphorylation of 
eIF2α. Translational control fine tunes rapid responses and flexibly to external signals and various 
forms of cell stress 
76. The phosphorylation of eIF2α occurs under situations often associated with 
mitochondrial dysfunction such as the unfolded protein response, decreased ATP levels and 
induction of oxidative stress 
77, 78
. Fusaric acid significantly elevated the expression of p- eIF2α 
across all tested energy substrates (Fig 5D-F). There are several ways in which FA can contribute to 
inhibited protein translation including down regulation of protein chaperones 
39
, loss of ATP 




Extensive post-transcriptional, translational and stability regulation along with accumulation and 
degradation of corresponding mRNAs are essential for protein abundance 
79
. MicroRNAs are 
negative regulators of protein expression and have become increasingly recognised as key role 
players in cell metabolism and stress responses. MicroRNAs associate with their mRNA targets 
through base pair complementarity. Imperfect binding of miRNA to target mRNA causes 
translational inhibition 
80
, this results in loss of protein expression. SIRT3 and SIRT5 share a 
common seed sequence with miR-30c with partial complementarity. FA was able to significantly 
upregulate the expression of miR- 30c at all tested concentrations (Fig 5A-C).  This suggests FA 
can regulate SIRT expression at the epigenetic level by affecting post-transcriptional regulatory 
processes. Taken together the data validates that FA dysregulates translation of mitochondrial 
SIRTs 3 and 5 rather than transcription.  
 
SIRT3 is the primary mitochondrial deacetylase 
18
 involved in the regulation of OxPhos through 
reversible acetylation of succinate dehydrogenase and links the TCA cycle to OxPhos 
81
. SIRT3 
also plays a key role in anti-oxidant defences through activation of SOD2 
82
. SIRT5 is involved in 
the urea cycle as well as mitochondrial function through regulation of PDH 
64, 83
. Mitochondrial 
sirtuins SIRT3 and 5 functions as sensors and integrators of several distinct stress and metabolic 
inputs to coordinate responses for maintaining cellular homeostasis and aberrations to their 





Post-translational modifications of proteins such as changes to the acylation status are strongly 
interconnected to sirtuins and metabolic phenotypes in response to nutrient availability and 
metabolites. Loss of expression and activity of sirtuins have been shown to reduce metabolic 
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flexibility and has been implicated in insulin resistance, obesity and cancer. Ingestion of foodborne 
toxins such as the neglected mycotoxin FA and their roles in metabolic decline is under estimated 
especially when coupled to changes in acetylation and redox status of cells. Loss of function or loss 
of expression of these important mitochondrial regulators can lead to metabolic inflexibility as well 
as decreased anti-oxidant capacity of the cell. FA targets translational processes of SIRT 3 and 5 
which may contribute to disease initiation and progression.  
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6.1. Synthesis and conclusion  
 
The Fusarium fungi are known to have pathogenic potential to animals and plants. Fusarium 
metabolites are of economic importance due to their significant impact on public health and animal 
productivity across several countries. These toxins have been implicated in disease progression and 
initiation in both animals and humans. In the African context, where maize is the staple diet for the 
majority of the population, the emergence of highly prevalent but neglected fusariotoxins is of 
particular concern and will worsen an already precarious situation. The threat of human and animal 
exposure to these mycotoxins has led to ongoing elucidation of chemical structures, but the limited 
existence of mechanistic toxicological data has contributed to the difficulty in determining their 
toxic potential (Chilaka et al., 2017).  
Fusaric acid is a highly prevalent and ubiquitous fusariotoxin (Streit et al., 2013, Bacon et al., 1996) 
that acts with co-produced mycotoxins which results in synergistic toxic manifestations (Bacon et 
al., 1995, Porter et al., 1995). However, the toxicity of FA is grossly underestimated as only a few 
studies have determined its effects on organisms as an individual agent. In both plants and animals, 
FA is considered a putative mitochondrial toxin. Fusaric acid has multiple sites of action within 
mitochondria including the disruption of ATP synthesis through inhibition of the TCA cycle, 
OxPhos (Telles-Pupulin et al., 1996, Telles-Pupulin et al., 1998) and induction of mitochondrial 
depolarization (Singh and Upadhyay, 2014). However, there is a dearth of knowledge surrounding 
the molecular mechanisms of FA induced aberrant energy metabolism and inflammatory responses 
associated with mitochondrial toxicity.  
Enormous strides have been made in understanding mitochondrial dysfunction and associated 
pathobiology. This study provided key evidence to support the role of FA in perturbing 
mitochondrial homeostasis. Fusaric acid (24 hours, IC50 = 104 µg/mL) was found to down regulate 
the expression and activity of SIRT3, a critical deacetylase involved in the regulation of the 
mitochondrial stress responses. In addition, FA negatively impacts on mitochondrial biogenesis by 
significantly decreasing the expression of PGC-1α, NRF-1 and p-CREB, which are required for the 
transcription of nuclear encoded mitochondrial proteins. Loss of healthy mitochondria was shown 
to elevate ROS within FA exposed cells and as a consequence activate the NRF2 mediated 
cytoprotective response.  
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Classically, mitochondrial dysfunction has been linked to excessive ROS production and 
subsequent oxidative stress. In recent years, an intimate link between the release of mitochondrial 
DAMPs and innate inflammatory responses has been established. The NLRP3 inflammasome is a 
signalling platform that mediates the activation of caspase 1 and maturation of IL-1β in response to 
mitochondrial aberrations and stress. Inflammasomes are tightly regulated by a priming and 
activation step to ensure potent inflammatory responses are initiated only when needed (He et al., 
2016). Quantitative and qualitative data show that FA inhibits inflammasome priming, an 
observation supported by decreased expression of the transcriptionally active p65 subunit of NF-κB. 
In this study FA disrupted the canonical NF-κB activation through down regulation of up-stream 
kinases. The ability of cells to defend against oxidative stress is critical for the dampening of 
inflammasome activation (He et al., 2016). Mitochondrial dysfunction is known to elevate ROS and 
subsequently induce the release and translocation of NRF2 to the nucleus where it induces the 
expression of a cytoprotective gene battery, including PINK-1 (Murata et al., 2015). Fusaric acid 
elevated the expression of NRF2 and may therefore selectively up-regulate the autophagic clearance 
of damaged mitochondria via increased expression of PINK-1. Moreover, FA decreased the 
expression of p62 but increased autophagosome components (ATG5, ATG7 and LC3). Loss of 
NLRP3 priming and activation provides evidence for the immunosuppressive effects of FA. The 
implications of this study extend beyond that of immunosuppression. Severe downregulation of 
NLRP3 was found in cases of hepatocellular carcinoma. Furthermore, many studies highlight the 
protective effects of NRF2 (reviewed in (Marin et al., 2013)), however the excessive and prolonged 
expression of NRF2 has been shown to favour cancer progression (Jaramillo and Zhang, 2013).  
The ability of cells to defend against FA induced mitochondrial and oxidative stress may selectively 
manipulate cell phenotype leading to resistance against mitochondrial toxicity, thus allowing altered 
metabolic states. The roles of mycotoxins are often overlooked as potential agents in metabolic 
toxicity. Metabolic switching and subsequent metabolic inflexibility is associated with several 
pathologies including insulin resistance and cancer (Galgani et al., 2008). The metabolic shift in 
cancer cells is referred to as the Warburg effect and is characterised by the preferential use of 
glucose and shunting of pyruvate towards lactate production rather than OxPhos to generate ATP 
(Vander Heiden et al., 2009). Fusaric acid induces a cell phenotype reminiscent of the Warburg 
effect through constitutive stabilisation and expression of HIF-1α. This transcription factor 
transcribes for a set of genes (PDK1, LDH-A, PKM2) that inhibit the decarboxylation of pyruvate 
in the mitochondria and elevate lactate production. FA was shown to phosphorylate PDH E1α in a 
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PDK1 dependent manner and concomitantly increase the expression of both PKM2 and LDH-A 
suggesting a switch in metabolism away from OxPhos and toward glycolysis (shunt to lactate 
production). The capacity of FA to reduce viability and biomass of cells cultured in GAL and 
palmitate but not glucose suggest that FA renders these cells “addicted” to glucose. This is the first 
evidence to suggest that FA mitochondrial toxicity induces an adaptive cellular response to mitigate 
loss of mitochondrial function and compensate ATP production by enhancing glycolysis.  
Fusaric acid results in dysregulated mitochondrial stress responses and metabolic flexibility. 
Mitochondrial SIRTs are at the forefront of facilitating metabolism and mitochondrial homeostasis. 
In silico analysis showed FA to strongly bind to mitochondrial SIRTs (3 and 5) and impede their 
catalytic activity despite the presence of ample NAD
+
 levels. Analysis of protein expression of 
SIRT 3 and 5 revealed significant decreases despite elevated transcript levels. The transcriptional 
co-activator of SIRT 3 and 5, PGC-1α, was elevated and is in agreement with the observed mRNA 
levels.  However, upon further analysis of the transcriptional activation of SIRT 3 and 5 it was 
apparent that FA downregulates translation of these proteins. This was validated by elevated 
phosphorylation of EIF-2α and increased expression of miRNA 30c. Taken together these data 
suggest that FA targets translational processing of SIRTs.  
An accumulating body of evidence indicates that mitochondria are targeted by environmental 
toxins. This study highlights the importance of mitochondrial function and maintenance and the 
toxicities resulting from a neglected foodborne toxin. The data clearly indicates that FA is mitotoxic 
and induces cellular adaptive responses that lead to several toxic outcomes including suppression of 
pro-inflammatory cytokine maturation, enhanced glycolysis and lactate shunt to compensate for 
decreased mitochondrial outputs and aberrant SIRT regulation through manipulation of miRNA 
milieu. The mechanisms of FA toxicity can have radical alterations on mitochondrial function, thus 
reducing the availability of rate limiting mitochondrial-produced molecules (e.g., methyl groups for 
DNA methylation or cofactors such as NAD+, acetyl-CoA, and α-ketoglutarate) required for 
epigenetic histone and protein modifications.  
Vast strides have recently been made in understanding the biology and pathobiology of 
mitochondria, with mitochondrial dysfunction being implicated in many disease states including 
obesity, insulin resistance and cancer. This work contributes significantly to the role of dietary 
toxins in modulating a cross talk between cell stress responses and toxicological outcomes. These 
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findings add a novel aspect to the importance of mycotoxin toxicity particularly in the fields of 
mitochondrial and environmental toxicology.  
Mycotoxin producing fungal species are contaminants of agricultural commodities under a wide 
range of environmental conditions, making them common foodborne toxins. The economic burdens 
of mycotoxin contamination are of great consequences. Crops with large amounts of mycotoxins are 
often destroyed. Despite several national and international organizations that set recommended 
guidelines and maintain up-to-date information on regulatory statutes of principal mycotoxins, FA 
is often neglected. This thesis supports the classification of FA as an “emerging mycotoxin” and 
highlights the acute toxicity of FA. Studies on acute exposure to mycotoxins are highly relevant in 
the South African context. In developing countries, access to safe food is often limited, leading to 
the consumption of contaminated food. Because of this and together with the recently available 
information on frequent occurrence and in vitro mechanisms of FA toxicity, more data on the 
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Addendum A: Figure 1: Initiator caspases decreased at higher concentrations of FA while 
executioner caspases increased at higher concentrations of FA. Results are expressed as mean and 
SD (n=3). ** - control vs FA µg/mL p 0. 001-0.05, *** - control vs FA µg/mL p < 0.001 








Figure 2: BAX showed no significant difference between control and IC50 (104 μg/mL). Results are 












Figure 3: SMAC was significantly decreased (p=0.0199) between control and IC50 (104 μg/mL). 










Figure 4: ILP2 was significantly decreased (p=0.0352) between control and IC50 (104 μg/mL). 


















Figure 1: TNFα was significantly decreased (p=0.00435) and IL10 was significantly increased 
(p=0.0017) between control and IC50 (104 μg/mL). Results are expressed as mean and SD (n=3). * - 
control vs FA µg/mL p < 0.05, ** - control vs FA µg/mL p 0. 001-0.05 
 
Figure 2: Both total and phospho stat was significantly downregulated between control and IC50 
(104 μg/mL). Results are expressed as mean and SD (n=3). * - control vs FA µg/mL p < 0.05, ** - 














Figure 1: After 2 hours exposure to FA, the ATP output did not decrease below 50% for any of the 








Figure 2: After 4 hours exposure to FA, the ATP output did not decrease below 50% for any of the 
chosen substrates except GAL at the highest tested FA concentration (A – Glucose, B – High 
Glucose and C- Galactose). 
